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ABSTRACT
The effects of age and different diets on the activity of hepatic 
drug-metabolizing enzymes have been studied in rats. The enzymes studied 
were biphenyl 2- and 4-hydroxylase, p-nitrobenzoate reductase, 4-methyl— 
umbelliferone glucuronyltransferase, and cytochrome P-450 which is 
regarded as the major terminal mixed-function oxidase in hepatic 
microsomal hydroxylations•
The activity of these enzymes was determined at various ages 
between 6 and 100 days postnatum. The activity of each enzyme rose 
to a peak at a different rate. The peak was reached soon after weaning, . 
and activity then decreased with age to the mature level. With biphenyl 
2-hydroxylase, the activity fell rapidly after 31 days and disappeared 
altogether at 70 days.
During the first three weeks of postnatal life, undernutrition did 
not result in any significant change in the activity per g. liver weight 
of the enzymes studied. The total activity of the enzymes per liver was, 
however, lower,in the livers of the undernourished animals due to the 
smaller size of the liver.
In male weanling rats pair fed with respect to proteins with 
additional calories fed for 7, 14 and 28 days, the hepatic 
concentration of the enzymes was, in general increased# The activity 
of glucuronyl transferase was, however, depressed in the absence of 
additional calories and cytochrome P-450 was depressed in the presence 
of additional calories# In the animals fed the protein deficient diet 
with additional calories, the rise in the activity of biphenyl 4- 
hydroxylase was sufficient to compensate for the lower liver weight
so that the absolute amount per liver was the same as in the controls.
The adaptive response of this enzyme to the protein deficient diet in 
the in vitro studies was further suggested by the finding that the 
capacity of the body to metabolize biphenyl and excrete it as hydroxy- 
biphenyl in the urine was similar to that of control animals. Any 
possibility of a conformational change of the enzyme site being responsible 
for the adaptive response of the enzyme has been excluded. However, a 
correlation between the increase of biphenyl 4-hydroxylase activity 
and plasma corticosteroid level in protein deficient animals has been 
observed. The possibility of the adaptive response being mediated 
by corticosteroids has further been supported by the increase in the 
concentration of biphenyl 4-hydroxylase as a result of corticosterone 
administration in well-fed animals.
The current investigation has been extended by a study of the 
effect of substitution of starch by sucrose, glucose, fructose or an 
equimolar mixture of glucose and fructose on the activity of drug- 
metabolizing enzymes in growing rats. The presence of sucrose in the 
diet at concentrations of either 60$ or 10$ depressed activity of 
biphenyl 2- and 4-hydroxylases and level of cytochrome P-450. Other 
disaccharides, such as lactose or maltose did not have the same effect.
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CHAPTER I 
Principles of Drug Metabolism
A. GENERAL
1. INTRODUCTION
The environment in which we live contains innumerable non-nutrient 
chemicals of differing nature and origin, A number of compounds may be 
introduced into the body either by design or accident that are not normal 
constituents of the body. These non-nutrients include food additives, 
such as, preservatives, antioxidants, sweeteners, flavours and colours; 
therapeutic drugs; cosmetics; detergents; pesticides and industrial 
chemicals. These substances are ’foreign' to the major metabolic 
pathways of the body concerned with the metabolism of nutrients, and 
have variously been called 'foreign compounds', 'xenobiotics' or 
'anutrients'. In addition to these synthetic foreign compounds, a 
wide variety of plant foodstuffs contain anutrients belonging to various 
chemical groups, such as, terpenoids, alkaloids, ethers, flavonoids and 
cyanogenic glycosides, A  number of 'cyanogenetic' plants are commonly 
eaten by man or domestic animals, and include cassava (manioc), yam, 
maize, sugar cane, sorghum, linseed pulses and cycads (Montgomery, 1965), 
Similarly, nitrile compounds ({3-amino-propionitrile) with potent 
neurotoxic properties have been isolated from Lathyrus and Vicia seeds, 
which are very commonly consumed by people in many developing countries 
Tinder conditions of economic stress. Many sulphur-containing compounds 
are present in vegetables. These include ally 1 sulphide [(CH^CHC 
in onions and garlic; dithiolisobutyric acid [ (HSCH^gCHCOOH], in 
asparagus and the methyl ester of S-methylthiopropionic acid [CHgSCHgCOOCHg], 
in pineapple. These compounds are all potentially toxic if they accumulate 
in the body.
Since these substances are toxic in large doses and are modified in 
the body and excreted in the form of less toxic substances, earlier workers
believed that they underwent a process of ‘detoxication’ in the body 
whereby they were rendered relatively harmless. The term 'detoxication* 
was then applied to the metabolism of any foreign compound.
The majority of chemicals normally regarded as foreign to the 
body are metabolized and transformed into other substances, irrespective 
of whether the foreign chemical is toxic or innocuous. In the case of 
toxic compounds, metabolism can play an important role in reducing or 
increasing the toxic effects, for a compound may produce signs of 
poisoning either because it is toxic per se or because it is converted 
in the body into a toxic substance. The extent to which a toxic 
substance can exert its deleterious effects may depend therefore on 
how effective the body is in metabolizing it. If a compound is toxic 
per se and is transformed in the body to a less toxic or non-toxic 
metabolite, the more rapidly it is metabolized the less will be the 
toxic effect of a given dose. On the other hand, if it is metabolized 
to a more toxic agent, the more rapidly it is metabolized the greater 
will be its toxic effect.
Malnutrition is prevalent in many parts of the world. Such 
prevalence may occur either due to food shortage in developing countries 
or for an iatrogenic reason in affluent societies. Malnourished subjects 
are prone to a variety of diseases which are being treated increasingly 
with drugs; both the drugs and the disease may affect metabolic processes 
independently or jointly. The question of nutrition, drugs, and their 
interrelationships, therefore’, becomes pertinent.
Apart from using drugs for treating diseases, the use of pesticides 
is progressively increasing for food production throughout the world,
and perhaps their usefulness is greatest for'producing more food in 
developing countries (Stoewsand, Broderick & Burke, 1970) where 
populations exist on nutritionally inadequate diets.
Thus the question which needs to be considered is whether 
malnutrition can impair detoxication mechanisms. If dietary 
deficiencies decrease the efficiency of detoxication mechanisms, 
then it may be supposed that acute and chronic xenobiotic toxicity 
would be more frequent and deleterious in poorly nourished persons 
than in well nourished ones.
2. SITE OF DETOXICATION
The principle site of the detoxicating mechanism is in the liver, 
and the enzymes involved are mainly localized in hepatic microsomes 
(Brodie, Gillette and LaDu, 1958). The microsomal fraction is 
composed of fragments of the endoplasmic reticulum of which there are 
two types: rough surfaced in which the surface is studded with ribosomes, 
the sites of protein synthesis, and smooth surfaced which has no 
ribosomes. Fouts (1961) reported that drug metabolizing ensymes in 
liver microsomes are concentrated in the smooth membrane of the 
endoplasmic reticulum. Remmer and Marker (1965) confirmed these 
findings by showing that treatment of animals with phenobarbital, an 
inducer of drug metabolizing enzymes (Kato, Chiesara and Vassanelli*
1962; Remmer and Marker, 1963), caused a marked proliferation of the 
smooth surfaced membrane of the endoplasmic reticulum of the liver cell, 
whereas, rough-surfaced endoplasmic reticulum which contains ribosomes 
remained unaffected. The result does, however, depend on the time that 
elapses between the administration of phenobarbital and the death of the 
animal. This was brought out in the-study by Orrenius and Emster (1964)
who showed that administration of phenobarbital first'gave rise to 
increased levels of aminopyrine N-demethylase, NADPH-cytochrome C 
reductase and cytochrome P-450 in the rough-surfaced vesicle fraction, 
which was examined 6 hrs. after a single phenobarbital injection#
Between 6 and 12 hrs., the increase began to level off in the rough 
vesicle fraction and enzyme levels increased at a progressive rate in 
the smooth vesicle fraction. Repeated administration of phenobarbital 
resulted in the accumulation of smooth-surfaced membrane highly active 
in drug oxidation (Orrenius, 1965). These studies indicate that the 
ensyme synthesis occurs in the rough-surfaced reticulum, but this, 
when saturated with enzyme, appears to lose its ribosomes to become 
smooth surfaced reticulum (Emster and Orreni us, 1965).
These enzymes are also found, but to a lesser extent, in other 
tissues, e.g., kidney, lung, skin and gastrointestinal tract.
3. DETOXICATION MECHANISMS
A large variety of foreign compounds are metabolized in the body 
in two phases of reactions (Williams, 1967). In the first phase there 
occur all the reactions which can be classified as oxidations, reductions 
and hydrolyses which result in the introduction or unmasking of 
functional groups rendering a non-polar compound polar, or a polar 
compound to be more polar and hence more readily excreted than the 
original compound. These functional groups often act as a centre 
for the second phase of metabolism in which a synthetic step occurs so 
that the compound is conjugated with an endogenous molecule. The products 
of the second .phase, so called conjugated products, are usually water 
soluble acids which are readily excreted. Most drugs or foreign 
compounds are metabolized by both phases of reactions. . However, there
are some compounds, particularly when a compound already possesses 
a functional group, that often undergo only phase II reactions. Thus 
benzoic acid is primarily conjugated with glycine and glucuronic 
acid to form hippuric acid and benzoyl glucuronide respectively, and 
undergoes oxidation to give hydroxybenzoic acid only to a small extent,
(a) First phase reactions.
The types of reactions catalyzed by the microsomal drug metabolizing 
enzymes in the first phase are listed in Table 1. Although this list 
is by no means complete, it represents the diversity of these reactions*
Table 1. Types of reactions catalyzed by drug metabolizing enzymes
I. Oxidative reactions
Aromatic hydroxylation: aniline ---- —•> p-aminophenol
Aliphatic hydroxylation: hexobarbital  > oxohexobarbital
N-Demethylation: aminopyrine   aminoantipyrine + formaldehyde
p-chloro-N-methylaniline — ---- > p-chloroaniline +
f ormaldehyde
0-Demethyl at ion: o-nitroanisole--- — — > o-nitrophenol
S-Oxide formation: chiorpromazine  — — > chlorpromazine sulphoxide
II. Reductive reactions
Nitro reduction: p-nitrobenzoic acid  - — > p-aminobenzoic acid
Azo link reaction: 4—dimethyl ami no azobenzene------ > aniline +
p-dimethylaminoaniline.
(i) Mixed function oxidation reactions
It is well known that microsomal systems responsible for the 
reactions (Table l) are NADPH- and 0^- dependent (Brodie et al, 1958). 
The same requirements have also been demonstrated with the systems 
which hydroxyl ate phenylalanine and steroid hormones. It has been 
established that molecular oxygen is incorporated into the substrate 
molecules in the hydrosylation of phenylalanine (Mason, 1957) and 
steroid hormones (Kaufman, 1957). Similarly, incorporation of 
molecular oxygen into substrates has been demonstrated in the 
oxidation of acetanilide (Posner, Mitoma, Rothsberg and Udenfriend, 
1961) and trimethylamine (Baker and Chaykin, 1962) by liver microsomes# 
This suggests that in liver microsomes NADPH reduces a component which 
in turn reacts with molecular oxygen to form an 'active oxygen* 
intermediate. The 'active oxygen' seems to be involved in the 
oxidation of a variety of substrates by a group of non-specific 
enzymes in microsomes. Gillette (1962) formulated the following 
coupled reactions for microsomal hydroxylation:
1. NADPH + H+ + A — ---- — > AHg + NADt>+
2. AHg + Og ----------:---> "active oxygen"
3. "active oxygen" -f drug  " ' ' > oxidized drug + A 4- BkO
NADPH + 9g + drug = NADP + H^O + oxidized drug
where A represents a microsomal flavoprotein, NADPH-cy to chrome C 
reductase•
(ii) Role of cytochrome P-450 in mixed function oxidation reactions 
Qmura and Sato (1962, 1964) ishowed that liver microsomes contain
a haemoprotein, the reduced form of which combines with carbon monoxide
to give a soret peak at 450 m[i. They have provisionally called this
haemoprotein 'Cytochrome P-450' and suggested its importance in 
electron transport in liver microsomes. More recently, Remmer. 
and Marker (1965); Kato and Gillette (1964) and Orrenius and 
Emster (1964) reported that administration of phenobarbital to 
rats markedly increases the content of cytochrome P-450, the 
activity of NADPH-cy to chrome C reductase and drug metabolizing 
enzymes of liver microsomes. Furthermore, Orrenius and his 
associate (1964) found that carbon monoxide inhibits the oxidative 
N—demethylation of aminopyrine by liver microsomes. These findings 
suggest that P-450 may have some role in the oxidation of drugs in 
liver microsomes. The schematic representation of the pathway 
(Figl.l) of electron transport for cytochrome P-450 reduction and the 
activation of oxygen for hydroxylation reduction was originally 
developed by Omura, Sato, Cooper, Rosenthal and Estabrook (1965).
P-450 (Fe±±±-0-0 -)
KOH
NADPHN fp _  ■ ..P-450 (I'ct±±- O")
NADP fpH: X  P-450 (Fc++)
•UFO
Fig. 1.1. Schematic representation of drug-oxidizing 
mechanism.'
fp: Flavoprotein, X: unknown factor, 
RH: Substrate.(drugs).
However, changes in hydroxylase activity in hepatic microsomes 
have frequently been correlated with changes in cytochrome P-450 
content, but there are many instances in which the activity is not . 
directly proportional to P-450 content (Kratz and Staudinger, 1967; 
Degkwitz, Luft, Pfeiffer and Staudinger, 1968). For example,
Davies, Gigon and Gillette (1969) found that species variations in 
ethylmorphine demethylation were closely paralleled by differences 
in the rate of cytochrome P—450 reduction and not by differences in 
cytochrome P-450 content cr NADPH-cy to chrome C-reductase activity.
These findings thus raised the possibility that the rate limiting 
step of ethylmorphine demethylation might be the rate of reduction 
of cytochrome P-450 by cytochrome P-450 reductase.
A number of investigators (Remmer, Schenkman, Estabrook, Sasame, 
Gillette, Narasimhula, Cooper and Rosenthal, 1966; Schenkman, Remmer 
and Estabrook, 1967) have shown that various compounds cause two types 
of changes in the visible absorption spectrum of hepatic microsomal 
suspensions even in the absence of NADPH. The 'type 1' spectral 
change is characterized by the appearance of a trough at 420 nm and a 
peak at 390 nm when compounds such as hexobarbitone or aminopyrine are 
added to the sample cuvette. The ’type 2’ spectral change is 
produced by compounds such as aniline and pyridine, and is characterized 
by the appearance of a trough at 390 nm and a peak at about 430 nm.
The intensity of the spectral change is related to the concentration 
of the substrate* Since these spectral changes presumably represent 
complexes of the compounds with cytochrome P-450, the rate limiting 
step of reaction might be the reduction of the substrate cytochrome 
P-450 complex and not necessarily cytochrome P-450 per se.
Thus at the present time the general mechanism for the oxidation 
of drugs is thought to involve the following reactions (Gigon, Gram 
and Gillette, 1969): oxidized cytochrome P-450 reacts with the drug 
to form a drug cytochrome complex, which is reduced by NADPH- 
cytochrome C-reductase, either directly or indirectly through an 
unidentified carrier (non-haem bound iron protein). The reduced 
cytochrome then combines with molecular oxygen to form an 'active1 oxygen 
complex, which breaks down to give oxidized cytochrome P-450 and 
oxidized drug. The sequence may be represented as follows:
v NADPH. H+
Drug + P-450(ox) ^----------Drug-P-450(ox) •----------> Drug-P-450(red)
P-450
reductase
• ■.■  >Drug-P—450.09 ----•> Oxidized drug +- P—450(ox).
(red)
It has now been reported that the operation in liver microsomes 
of the electron-transfer system is not only characterized by P-450, 
but also by another haemoprotein, cytochrome b- (Sato, Nishibayashi and
O ' .
Ito, 1969). As illustrated in Fig. 1.2, this system consists of
ascorbic, acid
> fP.NADH •> Cyt. b ■—> CN-sensitive 
factor
fatty acid 
desaturation
NADPH ■> drug hydroxylati on
Fig. 1.2 Electron-transfer pathways in liver microsomes, indicating
their relationships with functions. fP^, NADH-Cytochrome b^-
reductasr flavoproteinf fP^, NADPH-specific flavoprotein, 
usually called NADPH-cytoehrome c_ reductase.
two interconnected chains, each containing one of the two haemoproteins. 
While NADH is the major source of reducing equivalent for the chain 
involving cytochrome h^, P-450 is reduced by electrons derived mainly 
from NADPH.
It is known that P-450 acts as the oxygen activating enzyme
(Omura at al, 1965) as well as the site of substrate interaction
(Remmer, Schenkman, Estabrook, Sasamej Gillette, Narsimhulu, Cooper
and Rosenthal, 1966) for oxidative transformations of various
lipophilic foreign compounds and possibly also of steroids. The
'function of cytochrome b_, on the other hand, had remained unclarified
for a long time until Sato and his colleagues (1969) suggested a role
for this cytochrome in oxidative desaturation of fatty acids. Cytochrome
b- seems to serve as a relay station where electrons from NADH, NADPH o
and ascorbic acid are passed to an unidentified cyanide-sensitive factor,' 
which probably activates oxygen for the desaturation process (Oshino,
Imai and Sato, 1967).
The elucidation of molecular mechanisms of these important 
reactions requires knowledge of the properties of the two haemoproteins. 
However, P-450 is firmly bound to the microsomal membrane and readily 
convertible by various treatments to an inactive and spectrally modified 
form called P-420 (imai and Sato, 1967). Therefore, it has never been 
isolated in its native form from microsomes. Because of this, P-450 
in liver microsomes has so far been studied mainly by difference 
spectrophotometry. Although this technique has proved very useful, 
a more direct approach is desired to establish the molecular properties 
of P-450. In contrast, cytochrome b^ has been highly purified from 
liver microsomes and characterized in detail (Strittmater, 1963).
(iii) Role of cytochrome P-450 in reduction of nitro compounds
In addition to the oxidative enzyme systems the endoplasmic 
reticulum of the liver also contains enzymes that reduce foreign 
compounds. These enzymes catalyze the reduction of aromatic nitro 
and azo compounds to amines (Fouts and Brodie, 1957). The bes± 
known example of azo reduction is the reduction of prontosil to •
sulphanilamide. Other examples are reductive cleavage of
dimethylaminoazobenzene and azobenzene. All the azo compounds 
are not however reduced by mammalian azo reductase. A number of 
such compounds have been found to be reductively cleaved after oral 
administration but not after intraperitoneal injection (Daniel, 1962;
Barrett, Pitt, Ryan and Wright, 1965). These compounds are then 
apparently reduced by bacterial azoreductase. Nitro compounds such 
as chloramphenicol, p-nitrobenzoic acid and nitro benzene are reduced 
to primary amines by the enzyme(s), localized mainly in the microsomes of the 
liver. Presumably the reaction proceeds through the aromatization 
of the nitroso and hydroxylamine derivatives (Fig. 1.3).
NO NHOH NIL
> > >
Nitrobenzene Nitroso
benzene
Phenyl
hydroxyl
amine
Aniline
Fig. 1.3• Pathway of nitrobenzene reduction.
Unlike the microsomal azoreductase, the nitroreductase is active
under anaerobic conditions but is virtually inactive in air. Both
reductase systems, however, are flavoproteins', having FAD as their 
prosthetic group, and their enzymic activities are greatly increased 
by addition of riboflavin, FMN or FAD. Kamm and Gillette (1963) 
suggested that microsomal enzymes, e.g. NADPH-cytochrome c reductase
nitro reduction, and the degree of inhibition is proportional to the 
amount of cytochrome P-450 bound as the carbon monoxide complex. On 
the basis of these findings, they postulated that the reduction of 
p-nitrobenzoate to p-aminobenzoate by liver microsomes is mediated by 
cytochrome P-450. The relationship between cytochrome P-450 and nitro 
reductase was further supported by the findings that changes in nitro 
reductase activity paralleled changes in the amount of cytochrome P-450 
in liver microsomes:
(a) impairment of the enzymatic activity caused by prior 
administration of CCl^ closely paralleled the decrease 
in microsomal cytochrome P-450, and
(b) induction of nitro reductase by prior treatment of rats 
with phenobarbital paralleled increased in cytochrome 
P-450 in liver microsomes.
or NADH-cytochrome b^ reductase, reduce FAD to FADH^ which then
reduces the foreign substrate non-enzymatically.
cytochrome c reductase
NADPH. H+ + FAD -> FADHg + NADP
n on-enzymic
SFADHg +- R.N02 -> 3FAD + R.NB^ +
Gillette, Kamm and Sasame (1968) found that carbon monoxide blocks
Further studies on the reduction of p-nitrobenzoate by liver
microsomes showed that nitroreduction is inhibited by substances which 
cause type 2 spectral changes, but not by those which cause type 1 
spectral changes (Sasame and Gillette, 1969).
Since, most of the NADPH-dependent liver microsomal enzyme 
systems that catalyze the oxidation of various steroids and drugs 
are also mediated by cytochrome P-450, these findings suggest that 
the reduction of nitro- compounds and the oxidative reactions are 
catalyzed by similar electron transport systems. Probably cytochrome 
P-450 and cytochrome bg in their reduced form, can reduce nitro compounds 
as non-enzymic reducing agents.
00 Second phase reactions.
The second phase of drug metabolism consists of synthetic reactions 
or conjugations which are concerned not only with the drugs themselves 
and their phase 1 products, but also with compounds which are provided 
by the body and derived from materials involved in normal carbohydrate, 
protein, and fat metabolism. Conjugation is probably second only in 
importance to hydroxylation as a process by which foreign compounds are 
detoxicated in the body. The principle conjugating agents are glycine, 
glutathione (cysteine), methionine and glucuronic acid. The most 
common type of conjugation is the formation of an ester linkage with 
glucuronic acid produced from glucose (Marsh and Levvy, 1963).
A conjugation reaction requires, among other things, an 'active1 
intermediate compound usually a nucleotide, and a transferring enzyme#
DTP 2NAD
Glucose ---->G—6—P— — >GHHP T ->UDPG ■^ttdPGA + 2NADH.H
uridyl transferase ►P-de hydro genas e
From the point of view of mechanism, there are two lands of conjugation 
reactions, one in which the conjugating agent forms part of the active 
intermediate and the other in which the drug or its phase I metabolite 
forms part of the active intermediate. In general terms these reactions 
can be expressed as follows:
(l) Conjugating activated , , .• , energy * . . .  drug and_ .agent------- ----- “ — > conjugating ---“----> conjugated
agent drug
nucleotide "
activated conjugating
c
drugtransferase
An example of the first is the glucuronide conjugation, in which the 
activated form of the conjugating agent is uridine diphosphate glucuronic 
acid (UDFGA) and the transferring enzyme is glucuronyl transferase#
UDP
UDPGA + ROH -r ■■■■ _ , ■—  --------> R0CJIn0fl + UDPglucuronyl transferase 6 9 6
(p-D-gluc opyrano- 
siduronic acid)
The formation of hippuric acid is an example of the second and in this 
case benzoic acid is the foreign compound which is converted into an 
active form, benzoyl-CoA, and glycine N-acylase is the transferring 
enzyme •
(c) Two phase reactions and toxicity
An initially toxic compound may be converted into less toxic 
substances (detoxication) or an initially non-toxic compound may be 
converted into more toxic metabolites (intoxication) by phase I reactions. 
The new functional group may also subsequently undergo phase II reactions
(conjugation) generally resulting in deactivation of drugs and usually 
a decrease in toxicity. Examples of some of these processes are shown 
below:
phase I phase, II
Phenobarbitone ----- ;--- ;--- > p-hydroxy --------------> p-hydroxy-
(active) deactivation phenobarbi- phenobarbitone
tone glucuronide
(inactive) (inactive
' . * excretory produc
phase I phase II
Pronto si 1 -----t ~.— ;p---- > Sulphanil amide ---------- -> N f -acetyl
(inactive) a° 1Va 10n (active) sulphanil amide
(inactive 
excretory produc
B. SOME FACTORS AFFECTING 
DRUG METABOLISM
The rate at which each of the detoxicating reactions proceeds, and 
its relative importance,may be affected by a variety of factors, resulting 
in changes in the pattern of metabolism of a foreign compound and 
differences in toxicity# These factors are mainly: species, strain 
(genetic factors), age, hormones, administration of foreign compounds and 
nutritional status. Furthermore, detoxication reactions have a direct 
bearing on the pharmacological reactions of drugs. Because of these, 
a realization of the effect of these factors on detoxication reactions 
is of prime importance in the pharmacological evaluation of a drug and 
in the evaluation of the capability of detoxicating a foreign compound 
present naturally or artificially in foods.
•
1. Species differences
The importance of species differences in drug metabolism in understanding 
the mechanism of action of many drugs has become increasingly evident.
It would appear that the increasing interest in the subject stems from 
the premise that improved understanding and broader knowledge of species 
differences in drug metabolism will greatly- improve our abilities to 
predict the pharmacologic and toxicologic properties of a given compound 
in man from experimental data obtained in animals. This has been 
pointed out in studies on the metabolism of several clinically useful 
drugs such as meperidine, phenylbutazone, ethyl biscoumarin acetate 
and pentobarbital (Conney and Bums, 1962). Quinn, Axelrod and Brodie:
(1958) investigated species differences in drug metabolism systematically 
by comparing the rates of metabolism of hexobarbital, antipyrine, and 
aniline in a number of species. They found that the mouse metabolized 
hexobarbital 20 times and antipyrine 60 times more rapidly than man.
A good correlation between sleeping time and biological half life of 
hexobarbital was demonstrated. For example, hexobarbital disappeared 
so rapidly in the mouse that the effect of 100 mg/kg body weight of the 
drug lasted only a few minutes, while in the dog the drug had a long half 
life and an action that persisted for many hours. The activity of the 
hexobarbital metabolizing system in the liver microsomes was shown to be 
inversely related to the duration of drug action. The enzyme activity 
in mouse liver was about 17 times greater than that in the dog’s liver. Species 
differences in the duration of hexobarbital action can thus be explained by 
differences in the activity of the enzyme system that metabolizes the 
drugs. Similarly, a large number of drugs have been extensively 
studied by several investigators , and they showed that the rate of metabolism 
of these drugs varies with the species (Hucker, 1970). Most comparative 
studies of drug metabolism in different species however, have been 
descriptive in nature and almost no work on the detailed mechanism 
involved has been reported. However, prediction of species differences:-
in drug metabolism no doubt will depend on the variations in the enzymes 
which control phase I and phase II reactions# Parke and Williams (1969) 
suggested that these variations in enzyme activity can be due to 
differences in the following:
(i) the absolute amount or the specific activity of an enzyme,
(ii) the amount or nature of natural inhibitors of an enzyme,
(iii) the activity of an enzyme reversing the reaction; or
(iv) the activities of enzymic reactions competing for the same substrate#
2. Strain differences •
The genetic make-up of the individuals of a population within a 
given species may be important in determining whether a given individual 
will respond to enzyme inducers# Differences in phase I metabolism 
have been observed in the rate of metabolism in vitro of a number of 
foreign compounds in different strains of rats (Quinn, £t al, 1958;
Parke and Williams, 1969). Individual differences in the ability to 
metabolize drugs may have considerable bearing on therapeutic efficiency 
and toxicity. For example, hydrazine derivatives, such as isoniazid, 
hydralazine and phenelzine, and the sulphonamide, sulphadimidine are 
also deactivated by acetylation, but the rate of activity of liver 
acetyl transferase varies with the individual human subject with the 
consequent variation in the duration of pharmacological activities of 
these drugs (Evans, 1965). Besides these, the toxicity of foreign 
compounds may also be affected by genetic variations in the activity of 
enzymes that are concerned only indirectly in the metabolism of these, 
substances. For example, a number of drugs and other compounds, such as 
divicine and isouramil, pyrimidines that are present in the broad bean, 
produced haemolytic anaemia in certain susceptible individuals who have 
been found to have abnormally low levels of glucose-6-phosphate 
dehydrogenase activity in their red blood cells (Mager, Glaster, Razin,
Izak, Bien and Noam, 1965).
3• Sex hormones
It has been known for many years that the duration and intensity of 
drug action is often greater in the adult female rat than in the adult 
male (Hoick, 1949). Quinn et al (1958) provided an explanation for 
this difference with respect to hexobarbital by finding that the enzyme 
that metabolizes this drug is less active in females than in male rats.
They also investigated whether the observed sex differences may be related 
to the effect of sex hormones. Male and female rats were given oestradiol 
and testosterone respectively for several weeks before administration 
of hexobarbital. Oestradiol treatment elicited a marked increase in the 
sleeping time of males, a decrease in the rate of drug metabolism in vivo, 
and a decreased capacity of the liver microsomal system to metabolize 
hexobarbital. In contrast, treatment with testosterone produced a decrease 
in the sleeping time of females and an improved capacity to oxidize 
hexobarbital•
The response of both sexes to hexobarbital was identical up to the 
age of 4 weeks, but at 5 weeks the superior performance of the enzyme in 
males was manifested by an abrupt decrease in the recovery time. The 
maximal difference between the sexes appeared in 6 weeks (Conney and 
Burns, 1962). It has been suggested that a balance between the male 
and female sex hormones is important in determining the drug enzyme 
activity, and that this balance is upset in the male at puberty.
However, in contrast to a sex difference in the rat, no such 
difference was observed for the metabolism or action of hexobarbital in 
guinea pigs, rabbits, cats and dogs (Quinn et al, 1958), but the results 
in mice are conflicting. These workers found no sex difference in this 
species with hexobarbital and little change in its rate of disappearance 
when sex hormones were administered. In another study, however, in
contrast to the situation in rats, male Swiss-Webster mice were affected 
by phenobarbital for a longer time than female, and the duration of 
action was decreased by treatment of the males with stilboestrol and 
increased by treatment of the females with testosterone (Westfall, Boulos, 
Shields and Garb, 1964).
More recently, Schenkman, Frey, Remmer and Estabrook (1967) showed 
that sex differences in drug oxidase activity of liver microsomes from 
rats is related to a difference in substrate affinity for the mixed 
function oxidase reaction, and not to a difference in the content of 
cytochrome P-450. These results showed that microsomes isolated from 
livers of male rats had over twice the magnitude of substrate (hexobarbital 
and aminopyrine) binding than did microsomes isolated from the livers 
of female rats.
In addition to the effects of male and female sex hormones, the 
hormones of the adrenal glands, the thyroid and pancreas are also known to 
have some effects on the metabolism of foreign compounds. Adrenalectomy 
of male rats impairs the metabolism of foreign compounds and this is 
reversed by administration of prednisolone. Pre-treatment with anabolic 
steroids such as 19-nortestosterone also stimulates the hepatic microsomal 
enzymes (Booth and Gillette, 1962).
4• Foreign compounds
The stimulatory effect of foreign compounds on liver microsomal 
enzyme activity was first observed by Brown, Miller and Miller (1954), 
who studied dietary factors that influence the activity of hepatic 
amino-azo-dye ^-demethylase in mouse and rat liver in vitro. Thus 
the livers of mice fed a commercial chow diet for 7 days had twice the 
dernethylation activity of those from mice fed a purified diet, although
both diets promoted equally good growth and reproduction# The 
effectiveness of the chow diet to enhance the demethylation activity was 
believed to be due to its content of oxidized or peroxidized steroids 
and other organic peroxides produced during the processing and 
storage of the diet# Commercially obtained liver powder, tryptone, 
casitone, and aged or oxidized cholesterol preparations stimulated 
azo dye demethylase activity when fed in the diet; while freshly 
prepared preparations of liver, brain, milk or recrystallized 
cholesterol were inactive. Several peroxides and oxidized steroids 
preparations such as ascaridole, pinane hydroperoxide, hydrogen 
peroxide, oxidized dihydro cholesterol and oxidized ergosterol were 
active stimulators of the azo dye methylase system.
Subsequently, a large number of drugs and other chemicals have 
been shown to stimulate the activity of drug metabolizing enzymes 
in liver microsomes (Conney, 1967). They fit into one or two general 
classes typified by 3-methylcholanthrene and phenobarbital. The former 
are restricted almost entirely to polycyclic hydrocarbons, but the 
latter contain mainly chemically diverse drugs such as barbiturates, 
phenothiazines, chlorinated insecticides and phenylhydantoins• In 
addition to the increase in the activity of drug metabolizing enzymes, 
the administration of such inducing substances into an animal produces 
an increase in liver weight and in the concentration of microsomal 
proteins. The simultaneous injection of actinomycin D, puromycin or 
ethionine (inhibitors of protein synthesis) in conjunction with the 
inducers has been found to suppress their various inductive effects.
Thus it has been concluded that the increase in enzyme activity after 
the administration of certain foreign substances probably represents 
new protein synthesis (Conney, 1967).
C. EFFECTS OF AGE AND NUTRITION 
ON DRUG METABOLISM
1* Age
Jondorf, Maickel and Brodie (1959) reported that newborn mice 
and guinea pigs are deficient in certain drug metabolizing enzymes in 
liver microsomes. These include the enzyme system that N-demethylates . 
monomethyl-4-aminoantipyrine and aminopyrine, O-dealkylates phenacetin, 
oxidizes hexobarbital, and conjugates phenolphthalein as the 
glucuronide. Fouts and Adamson (1959) studied a number of drugs 
that are metabolized by enzymes present in liver microsomes; and 
the pathways studied included the oxidation of hexobarbital, the 
N-dealkylation of aminopyrine, the deamination of amphetamine, the 
hydroxylation of acetanilide, the oxidation of the ring sulphur of 
chlorpromazine, and the reduction of the nitro group of p-nitrobenzoic 
acid. They found that newborn rabbits did not have any activity of 
these enzymes, but some activity appeared at two weeks after birth, and 
at four weeks the activity was about equal to that found in the adult.
Kato, Vassanelli, Frontino and Chiesara (1964) studied the in vitro 
metabolism of hexobarbital, pentobarbital, meprobamate, carisoprodol and 
strychnine, and the in vivo metabolism of pentobarbital, meprobamate and 
carisoprodol in female rats. In these studies the newborn showed only 
a very low metabolic activity, but this increased progressively until 
30 days of age. after which it gradually decreased.
A study in the rat of the development of hepatic aniline hydroxylase 
and ethylmorphine demethylase, showed that both the total activities and 
the Km values of these enzymes increased during the first few weeks after birt 
but there was n e i t h e r  correlation between activities of the two enzymes 
nor between either of them and the hepatic cytochrome P—450 content (Gram,
Guarino, Schroeder and Gillette, 1969). Other workers have studied 
the development of microsomal glucuronyl transferase in the liver 
of newborn rabbits (Flint, Lathe, Ricketts and Silman, 1964), the 
glutathione conjugation of sulphobromophthalein in mouse liver 
(Krasner, 1969), the hydroxylation of 7,12-dimethylbenz[a]anthracene 
in rat liver (Sims and Grover, 1967), and a number of oxidative, 
reductive, hydrolytic and synthetic drug-metabolizing enzymes in the 
liver of the pig (Short and Davis, 1970). All these studies have 
shown a characteristic development of these enzymes during the first 
4—6 weeks after birth.
Fouts and Hart (1965) reported that treatment of newborn rabbits 
with phenobarbital enhanced the activity of liver enzymes that metabolize 
drugs, such as hexobarbital, aminopyrine, and p-nitrobenzoic acid. 
Treatment of rabbits with phenobarbital during the final week of 
pregnancy also increased the activity of these systems in the newborn, 
but drug metabolizing enzymes could not be stimulated before the last 
4 days of foetal life. From these results, these workers suggested 
a defective enzyme-forming mechanism before this time.
Recently, Kato and Takanaka (1968) showed that the effect of 
phenobarbital on the aminopyrine N-demethylation, hexobarbital 
hydroxylation, aniline hydroxylation and p-nitrobenzoate nitro reduction 
was much greater in young rats than in older ones. Thus it seems that 
the immature rats are intrinsically more responsive to enzyme induction 
by drugs than the adult ones.
2. Nutri tion
As early as 1882 it was noted by Rosenbaum that liver injury 
produced by arsenic or phosphorus resulted in a depletion of liver
glycogen. The ultimate development of this work was the use of 
glucose in the treatment of liver injury in both animals and man.
Although changes in liver glycogen are not now believed to influence 
hepatic damage, such studies in the early 1900s probably served to 
direct attention to dietary factors. The relationship of diet to 
the toxicity of drugs had been studied by a number of investigators 
(Drill, 1952), but it was not until 1914 that Opie and Alford investigated 
the relationship of diet to the effect of hepatoxic materials. They 
demonstrated that the degree of liver damage produced was increased by 
fat diets. With the diets then in use, least liver injury was observed 
when bread and milk were fed as compared with a high protein diet in the 
form of meat. Investigation of dietary factors has continued since 
that time, but the mechanism by which the various compounds and 
deficient diets produce liver damage was completely unknown until 
recently when it was shown that the activities of drug metabolizing 
enzymes can be altered by dietary and nutritional factors, hormonal 
status and the ingestion of foreign compounds.
(a) Starvation
Dixon, Shultice and Fouts (i960) have shown in their studies of the 
effect of nutrition on the activity of drug metabolizing enzymes that 
starvation for 36 hours depresses hepatic drug metabolism in male mice 
both in vivo and in vitro. They observed depressed activity of liver 
microsomal enzymes that catalyze the following reactions: oxidation of 
hexobarbital, N-dealkylation of pyramidon, hydroxylation of the aromatic 
ring of acetanilida, and the oxidation of the ring sulphur of chlor- 
promazine. However, the reductive pathways such as the reduction of 
aromatic nitro groups of p-nitrobenzoic acid and the reduction of the 
aromatic azo group of neoprontosil were either not affected or were
somewhat stimulated by starvation. In this study it was also shown that 
metabolism of drugs in these fasted animals returns completely to normal 
within 24 hours after access to food.  ^Dixon et_ al_ (i960) concluded from 
their studies that the decreased enzyme activity in the starved mice was 
due to an actual loss of microsomal enzyme, protein, and was not due to 
a deficiency of reduced co-enzymes, NADPH, or to the presence of 
inhibitors of the drug metabolizing enzymes. They also pointed out 
that electron micrographs of livers from starved animals revealed 
changes in structure of the endoplasmic reticulum from which microsomes 
are derived. Such structural changes, mainly a reduction in the amount 
of ergastoplasm, and changes in microsome sub-units, may be associated 
with marked depression of drug metabolism in starved animals as compared
*
with normal animals •
Kato and Gillete (1965) have shown, however, that in rats the 
effects of starvation depend on the sex of the animal. Thus in males 
starved for 72 hours, the activity of the enzymes which metabolize 
aminopyrine and hexobarbital and which are sex dependent, is depressed, 
whereas, the activity of the enzymes that hydroxylate aniline and which 
are sex independent, is enhanced. In contrast, starvation of female 
rats for the same period increases the activity of the enzymes which are 
sex dependent and sex independent. In support of this view, they were 
able to demonstrate that hexobarbital metabolism in castrated rats remained 
unaffected by starvation, while the metabolism of aminopyrine was enhanced. 
In this study, the activity of the enzymes which metabolize aminopyrine, 
hexobarbital and aniline was measured by measuring the rate of formation 
of 4-amino antipyrine, the rate of disappearance of hexobarbital and the 
rate of formation of p-aminophenol respectively,
Gram, Guarino, Schroeder, Davis, Reagan and Gillette (1970),
however, attempted to postulate more sophisticated explanations for
such results of the effect of starvation for 72hrs. on the drug
metabolizing enzyme systems using different concentrations of each
substrate. These workers pointed out that in male rats, starvation
elicited significant increases in apparent K and V for the
m max
N-demethylation of the ethylmorphine and in Vm tor the hydroxylation
of aniline* In female rats, starvation had no significant effect
upon any of these parameters except for an increase in V for aniline
max •
hydroxylation. Starvation of male rats also elicited a significant
reduction in the apparent K and V for the oxidation of hexobarbital ^  m max
and an increase in K for aminopyrine demethylation without affecting
V for the latter substrate. Thus, starvation elicits a complex 
max *
combination of changes in the kinetics of microsomal drug metabolism,
i.e., depending on the substrate used, starvation causes an increase,
no change or a decrease in either the apparent K or the V
m max«
The theoretical implications of this study are difficult to 
rationalize. To account for Gram and his associates’ findings, one 
might postulate the appearance or disappearance of enzyme activators 
or inhibitors5 allogteric enzymic effects produced by substances 
elaborated during starvation or conformational changes in the microsomal 
membrane or enzymes which might influence enzyme substrate binding.
It is of interest that re-feeding of female rats on the standard 
chow diet for 24 hours and 48 hours after the starvation for 72 hours 
resulted in a decreased activity of the enzymes which metabolize 
aminopyrine, hexobarbital and aniline to about 35 and 52$ of control 
values, respectively (ivato, 1967). These results are, however,
different from the findings of Dixon £t al_ (i960) who showed that in male 
mice fasted for 36 hours, the activity of the microsomal enzymes involved 
in oxidation of hexobarbital, N-dealkylation of pyramidon, hydroxylation 
of the aromatic ring of acetanilide, and the oxidation of ring sulphur of 
chlorpromazine returns completely to normal within 24 hours after access 
to food. However, these different findings may be due to sex or species: 
differences. - -•
Miettinen and Leskinen (1963) showed that the activity of uridine 
diphosphate glucose dehydrogenase per unit of liver weight is lower 
in rat liver fasted for 72 hours than that in fed rats. On the other, 
hand, p-glucuronidase activity is higher in the liver of fasted than 
of well-fed rats. Since glucuronide formation depends essentially on 
the adequacy of liver glycogen stores, it is not surprising that the 
biochemical function is depressed by starvation, not only because the 
specific enzyme proteins are deficient, but also because the co-substrate 
is depleted.
(b) Protein deficiency
Kato, Oshima and Tomizawa (1968) demonstrated that the toxicities 
of various drugs, such as pentobarbital, strychnine, aminopyrine, 
zoxazolamine and aniline, in male and female rats, weighing about 170g. 
and I50g. respectively, fed diets containing 50$, 18$, 10$ or 5$ protein 
for two weeks or fed a non-protein diet for 4 days were closely related 
to the rate of drug metabolism by liver microsomes and the activities of 
NADPH-dependent enzymes wore closely related to the amount of dietary 
protein intake. These workers also showed that the magnitude of decrease 
in the metabolism of pentobarbital, strychnine and aminopyrine in the 
male rats was greater than in the female rats.
In support of Kato and his colleagues, Marshal and McLean (1969) 
have shown that in adult male rats, fed a 3$ casein diet for 14 days, the 
concentration of cytochrome P-450 per unit of liver weight fell to 33$ 
of the control value. Furthermore, when rats fed a low protein diet 
were given phenobarbital, the level of cytochrome P-450 rose but still 
only to 25$ of the value found in control rats treated with phenobarbital.
More recently, Saggers, Hariratnajothi and McLean (1970) provided 
further supporting evidence that the activity of the quinine metabolizing 
enzymes per unit of liver weight was 23 times lower in rats fed a protein 
free diet for 7 days than that in control ones. However, these workers 
commented on their results in that, the very low rate of quinine 
metabolism by the liver preparations from protein depleted rat livers 
could be due to loss of enzyme activity during preparation, since P-450 
levels and aniline hydroxylation-were less severely depressed in these 
livers.
There is a widespread belief that protein deficiency and malnutrition 
increase the toxic effects of all foreign compounds, and this belief has 
been supported by the workers mentioned above. However, this general 
belief is not always correct. Campbell and Kosterlitz (1948) and McLean and
McLean (1966) showed that young male rats fed diets low in protein but 
adequate in lipotropic factors, vitamins and trace elements, are resistant 
to carbontetrachloride, and this evidence appears to be in contradiction with 
the results obtained by other workers for liver microsomal drug 
metabolizing enzymes. This is explained by the observations of Slater 
(1966) that CCl^ has to be 'metabolized' — probably to a free radical 
before it manifests its toxic properties.
+ —Cl •
CC14 ---- > C Cl4   — > CC13
McLean and Verschuuren (1969) showed that a protein-free diet 
fed for 7 days clearly protects young male rats against acute 
dimethylnitrosamine (DMN) poisoning. The LD^q is almost doubled
and liver damage is greatly reduced. The cause of this protective 
effect, however, could be explained by the evidence suggested by 
Magee and Lee (1964) that demethylation of dimethylnitrosamine leads 
to the formaxion of a toxic product, diazomethane (Fig.1.4) which is 
a powerful methylating agent that reacts with everything within range.
ILC—N—N = 0
3 Ia^c
Dimethylnitrosamine Monomethylnitrosamine
(unstable)
spontaneous
V
Methylation of cell *4---------—  CH^ = N = N
components
Diazomethane 
Fig.1.4. Activation of dimethylnitrosamine
Adlard, Lester and Lathe (1969) reported that the capacity of 
liver slices to conjugate and excrete bilirubin was similar in 
control rats and those fed a protein-free diet for 4 days. Studies 
with inhibitors and stimulators of the liver slice system 
conjugating bilirubin indicated that the characteristic effects of 
these compounds were not altered by pre-treatment of rats with the
+ 0 v L C - H  =
enzymatic 3 , 4 HCH0
demethylation ‘
H
protein-free diet. Woodcock and Wood (1971) reported that 
the rate of conjugation of p-nitrophenol and o-aminophenol 
in microsomal fraction per g liver weight are 64$ and 71$ 
higher in the liver of immature male Wistar rats fed a protein- 
free diet for 7 days than in the corresponding controls fed a 
diet containing 18$ protein. The differences are even more 
marked when the results are expressed 'per mg microsomal 
protein'. Since these workers did not find any significant 
difference in the activity of microsomal UDPGA pyrophosphatase 
between protein free fed and control fed animals, they postulated 
that protein free diet induces a real increase in glucuronyl 
transferase activity. These workers restricted the control 
diet so that the calorie intake of both groups was approximately 
the same. However, the biochemical changes underlying the 
higher than normal IJDP-glucuronyltransferase activity in protein 
deficient rats are not clear. The control mechanisms governing 
enzymatic activity operate for specific enzymes, so that 
adaptation of enzymatic activity follows dietary changes. In this 
context, Waterlow (1968) thought that there must be a wide range 
of adaptation, compatible with health, to different nutritional 
conditions. He has illustrated the fact that when
protein supplies are short, amino acids can be used more economically 
and the increase in enzyme activity may explain this mechanism. This 
adjustment of protein synthesis in response to a dietary deficiency is 
supported by the finding that in rats on a low protein diet there is an
increase in the activity of the amino acid activating enzymes in the 
liver (Mariani, Spadoni and Tomassi, 1963; Gaetani, Paolucci, Spadoni and 
Tomassi, 1964) and at the same time the activity of urea cycle enzymes is 
decreased (Schimke, 1962). The effect of these two changes would 
presumably be that in a rat on a low protein diet an amino acid 
entering the liver would have a greater chance of being incorporated 
into protein and a smaller chance of being deaminated than in a rat on 
a normal protein intake. \
(c) Mineral deficiency
Calcium deficiency (Dingell,Joiner & Hurwitz,1966), zinc deficiency 
(Becking and Morrison, 1970a) and magnesium deficiency (Becking and 
Morrison, 1970b) have been reported to result in a depressed activity 
of various drug metabolizing enzymes in rat liver. However, since 
calcium has been implicated as a vital factor in' membrane pore 
structure and thus may be involved in transport mechanisms, and 
zinc and magnesium are required for a variety of biochemical reactions 
in mammalian metabolism, it is not surprising that the activity of drug 
metabolizing enzymes is depressed by the deficiency of these nutrients.
■(d) Vitamin deficiency
The metabolism of many foreign compounds, particularly the muscle 
relaxant, zoxazolamine have been reported to be depressed by vitamin C 
deficiency in guinea pigs (Conney, Bray, Evans and Burns, 1961). The 
decreased activity of the zoxazolamine metabolizing enzyme system occurred 
at an early stage in vitamin C deficiency, and was observed before gross 
deficiency symptoms such as loss of weight, loss of hair and severe 
joint manifestations were evident. These workers did not, however, 
restrict the control diet so that the protein and calorie intake of 
both groups was the same.
Experimental and clinical evidence (Boxer and Rickards, 1952;
Wokes, 1958; Smith, 1961) suggests that the detoxication of cyanide 
received from various sources, such as dietary derivatives, tobacco 
smoke and infections (Wilson and Langman, 1966) takes place by­
conversion to thiocyanate and that this reaction may require vitamin
Thus cyanide toxicity may be increased in vitamin B ^  deficient 
subjects who are exposed to cyanide-containing sources. The sulphur 
containing amino acids, cysteine and cystine may also be involved 
in the detoxication of cyanide. The lower plasma level of these amino 
acids and the higher plasma level of thiocyanate among people whose 
staple diet is cassava, could be due to excessive cyanide detoxication 
(Osuntokun, Durowoju, Mcfarlane and Wilson, 1968). The protein intake 
of these people is often already limited due to economic stress, and 
if at the same time, the sulphur containing amino acids are continually 
used to detoxicate cyanide derived from cassava, then these people are 
not only exposed to the possibility of cyanide poisoning but also to 
depletion of nutritional substrates.
The study on the relationships between nutritional status and the 
metabolism of foreign compounds is still in the descriptive stage.
An enormous amount of work remains to be done before the various complex 
mechanisms regulating the metabolism of these substances will be 
understood.
D. CONCLUSIONS AND PLAN OF .PRESENT . STUDIES
1. Conclusions from the literature
The develo*pment of the components of rat liver has been studied 
extensively, but less information is available on the development of 
the activity of the hepatic drug-metabolizing enzymes than on many other
aspects. Furthermore, no work has involved a study of the correlation 
of the development of a number of these enzymes with the concentration of 
hepatic cytochrome P-450, which is believed to be the terminal oxidase for 
the hydroxylation of many drugs. Further, the development and the 
nature of the activity of the latent microsomal enzyme biphenyl 
2-hydroxylase (Creaven et al, 1965) have not so far been critically 
investigated.
Another most significant conclusion to emerge from the review is 
that, since the activity of drug-metabolizing enzymes is so dependent 
on the age of the animal, the study of interrelationships between 
nutritional status and drug-metabolizing enzymes on the basis of body 
weight but not on age is likely to be highly misleading. Furthermore, 
it is well known that when rats are fed a protein deficient or protein- 
free diet, they may become anorexic, and thus the amount of food eaten 
is reduced. With the exception of Woodcock and Wood (l97l) , none of 
the workers in this field appear to have used pair feeding, and most 
workers maintained their control rats on a normal pellet, stock diet, whilst 
their experimental animals were fed a synthetic diet. Clearly such diets 
differ in respects other than their protein content, and the other 
ingredients may themselves affect the activity of the enzymes. The 
activity of drug-metabolizing enzymes has, in fact, been found to be 
higher in animals fed a commercial chow diet than in those fed a purified 
diet (Brown et al, 1954).
Most of the studies so far reported of the effect of nutrition 
on the activity of drug-metabolizing enzymes have been done on adult 
rats. There seems to be no satisfactory evidence on the effect of dietary 
deficiencies on the development of detoxication mechanisms. Further, 
much of the work on the effect of a reduced intake of calories on the
drug-metabolizing enzymes has been done on rats in which the reduction 
has been acute (e.g. starvation), and no evidence has yet been reported 
of the effects of a chronic deficiency of calories restriction of
calorie intake).
Until recently, the kind of carbohydrate consumed in the diet was 
thought to be of minor importance. However, in recent years, it has 
been found that the ingestion of sucrose instead of starch by rats 
results in an increased amount of fat in the liver (Marshall and Womak, 
1954), increased levels of various enzymes (Freedland and Harper, 1958; 
Aitken, Robinson and Yudkin, 1967), and a significant fall in serum 
albumin (Brice, Coles, Jourdan and Macdonald, 1969). Dietary sucrose 
depresses the rate of oxidation of glucose and of lipogenesis from 
glucose in both liver and adipose tissue, and it has been suggested that 
these effects are due to an increase in the level of various enzymes in 
the metabolic pathways (Bender and Thadani, 1970). Substitution of diets 
rich in free hexoses for a standard diet containing starch in rats results 
in a considerable increase in the activity of most of the enzymes of the 
Emdem Mayerhof and pentose phosphate pathways, the citric acid cycle and 
amino acid metabolism (Fitch and Chaikoff, 1960; Weber, Banerjee and 
Bronstein, 1961). Rats fed on a diet high in fructose or sucrose also 
have raised plasma cholesterol levels (Allen and Leahy, 1966). No study, 
however, seems to have been made of the pattern of the activity of hepatic 
microsomal drug-metabolizing enzymes in rats fed various carbohydrate 
diets. Nevertheless, it would appear desirable to have some knowledge 
of the effect o^f various carbohydrates with particular reference to the 
effect of sucrose on the drug-metabolizing enzymes since it is evident 
that consumption of sucrose is steadily increasing (Yudkin, 1964) and in 
children drugs are often given in sucrose syrup.
2. Plan of present studies
Since it was decided to investigate the effect of nutrition in 
growing rats.on the activity of the enzymes involved in drug metabolism, 
the study of the effect of age on these enzymes becomes important, and 
this has formed the starting point of the present study (Chapter III)# 
Furthermore, from the literature review it seems that no systematic 
study of development had been made in which the activity of the various 
drug-metabolizing enzymes was determined in the same liver so that their 
interrelationships could be distinguished#
All the studies reported have shown a characteristic developmental 
pattern of the activity of hepatic microsomal drug-metabolizing enzymes 
during the first three weeks or so after birth in various mammalian 
species# Thus, early postnatal life is characterized by a unique 
anabolic tendency, and this could be an adaptive response necessary for 
survival after the mammal is bom. The immediate postnatal period is 
one of the most vulnerable phases in the life of an animal, at least in 
terms of its response to dietary modifications (Winick and Noble, 1966; 
Miller, 1970), and the anabolic response during this period depends to a 
considerable extent on an adequate supply of nutrients. The present 
study, therefore, includes the study of the effects of nutritional stress 
in early postnatal life on the activity of drug-metabolizing enzymes 
(Chapter IV).
The present investigation was extended to weanling rats subjected to 
chronic malnutrition. The experiments have been designed to eliminate some 
of the variables mentioned above, and the work has been limited to a study 
of the effects of a low protein diet with, or without, additional calories, 
on the activity of drug-metabolizing enzymes (Chapter V).
The present study was further extended to an investigation of the effects 
of different carbohydrates on drug-metabolizing enzymes in the livers of 
growing rats (Chapter VI).
CHAPTER II 
Experimentals
In order to study the effects of nutrition on drug metabolism 
it was necessary to select a number of parameters of hepatic function 
which would give a quantitative measure of the activity of enzymes involved 
in the metabolism of drugs. It was also desirable to use sensitive 
methods based on the formation of a product rather than on the disappearance 
of a substrate, and as the basic problem concerned the development, . 
depression or induction, of the drug metabolizing enzymes of the hepatic 
endoplasmic reticulum it was decided to follow the activities of the 
following enzymes:
'(a) Aromatic hydroxylation using biphenyl as substrate, which is 
metabolized by oxidation to 2- and 4-hydroxy biphenyl.
(b) Nitro reductase using p-nitrobenzoic acid as substrate which 
is metabolized by reduction to p-aminobenzoic acid.
(c) Glucuronyl synthetase using 4-methyl umbelliferone as the 
substrate which is conjugated to give 4-methyl umbelliferone 
glucuronide.
(A) Cytochrome P-450 which is regarded as the major terminal
mixed function oxidase in hepatic microsomal hydroxylations*
A change in nutritional status is often accompanied by a change of body 
weight, liver weight and the synthesis of protein, and thus it was 
necessary to measure these parameters after pretreatment of the animals 
with the different diets.
A MATERIALS AND METHODS
MATERIALS
(a) Substrates
Biphenyl, m.p. 70°C (B.D.H.), was purified as described by
Bridges, Creaven and Williams (1965) ; 4-methyl umbelliferone 
(Koch-Light), was recrystallized as described by Mead, Smith 
and Williams (1955) and p-nitrobenzoic acid (B.D.H., Ahalar), 
was used as supplied.
(b) Standards
p-Aminobenzoic acid, m.p. 187°C (B.D.H.), was recrystallized 
from aqueous ethanol; 2-hydroxy biphenyl, m.p. 57°C and 4—hydroxy 
biphenyl, m.p. 167°C (B.D.H.) were purified as described by 
Bridges et_ aL (1965) ; 7-hydroxycoumarin (umbelliferone) m.p. 225°C 
(Hopldns and Williams) was recrystallized from water (carbon); 
bovine serum albumin (Koch Light), calf thymus DMA (Sigma), and 
corticosterone (Sigma) were used as obtained, and 4-methyl 
umbelliferone glucuronide was obtained as a gift from Dr. M.G. Neale.
(c) Enzymes
p-Glucuronidase (K. & K« Lab.)
Glucose-6-phosphate dehydrogenase (Sigma).
(d) Cofactors
Nicotinamide-adenine dinucleotide phosphate(NADP);
reduced nicotinamide-adenine dinucleotide 
Glucose-6-phosphate (disodium salt, Koch Light); 
flavin mono, nucleotide, (FMN^ and uridine diphosphate 
a-glucosiduronic acid,(UDFGA), were all used as supplied.
These substances were all obtained from Sigma.
,(e) Buffers
Phosphate buffer (0.2M) was prepared from sodium hydrogen 
phosphate (A.R.) and sodium dihydrogen phosphate (a .r ); Tris- 
HC1 buffer (0.05M, pH 8.1 and 0.1M, pH 7.6) was prepared from 
Tris (hydroxymethyl) aminomethane and hydrochloric acid; acetate 
buffer (0.2M, pH 4.6) was prepared from sodium acetate and acetic 
acid; glycine buffer (0.5M, pH 10.4) was prepared from glycine and 
sodium hydroxide.
(f) Other reagents
Potassium chloride (B.D.H. Analar) was used as a l.l5^(w/v) 
solution, succinic acid (B.D.H.) was recrystallized from water, 
diphenylamine (B.D.H.) was recrystallized from ethanol, sodium 
nitrite (B.D.H.), ammonium sulphamate (B.D.H.) , N-l-naphthyl- 
ethylene-diamine dihydrochloride (B.D.H.), Tween 80 (polyoxyethylene 
sorbitan mono oleate, Koch Light), Triton X-100, sodium dithionite 
(Hopkins and Williams), Folin and Ciocalteau1s reagent (B.D.H.) 
and carbon monoxide (British Oxygen Company) were all used as 
supplied. Methylene chloride (B.D.H.) was washed by shaking with 
conc. HgSO^, IN NaOH and distilled water; dried over anhydrous 
sodium sulphate, and distilled at temperatures between 39 and 40°C 
before it was used.
(g) Solvents
All solvents were obtained from British Drug House Chemicals 
Limited, and were used as supplied.
(h) Inducing agents
Phenobarbital sodium (B-D.H.).
• analytical methods
(i) Preparation of liver fractions
All animals were killed by cervical dislocation at approximately 
the same time of day, i.e. 10 a.m. +_ 1 hour to avoid differences due 
to diurnal variation (Radzialowski and Bousquet, 1968). The livers 
were quickly removed, blotted on Whatman No. 1 filter paper to remove 
as much blood as possible, weighed and finally homogenized in ice- 
cold aq. 1.15/6 (w/v) KC1 using a glass homogenizer (2.4 cm. dia.) 
and a loose-fitting Teflon pestle (Potter and Elvehjem, 1936). The 
pestle was driven by a Black and Decker electric drill at a speed of 
2950 r.p.m. and two up and down strokes were used for each 
homogenization. The homogenate was diluted to make a 1 :4 dilution, 
i.e., 1.0 ml. KC1 solution contained the equivalent of 250 mg. of 
wet weight liver, and was then centrifuged in 50 ml. polypropylene 
centrifuge tubes in an M.S.E. 'High Speed 18' refrigerated centrifuge 
at 1°-4°C at 9500 r.p.m. (l0,000g.) • for ten minutes to remove debris, 
nuclei and mitochondria. The supernatant was carefully decanted and 
used in most enzyme assays as the '10,000g. supernatant’ • Homogenates 
were always kept cool in ice water.
For the preparation of the microsomal fraction an aliquot of 
the 10,OOOg. supernatant was centrifuged in an M.S.E. 'Superspeed 50' 
in a 10 x 10 ml. angle head at 40,000 r.p.m. (l00,000g.) for 60 minutes 
at a temperature between 1°-4°C. The supernatant was carefully 
decanted, the pellet rinsed with a few ml. of ice-cold 1.15$ KC1 to remove 
the adhering supernatant fraction, and then re suspended in the 
same volume of 1.15$ KC1 by gentle homogenization. This constituted 
the 'microsomal suspensions'.
i) Determination of hydroxylation of biphenyl
OH
hydroxy lati on
OH
Biphenyl 4-Hydroxybiphenyl 2-Bydroxybiphenyl
a. ’ In liver
Rabbit liver preparations hydroxylate biphenyl to 2- and 
4-hydroxy biphenyl (Mitoma, Posner, Reitz and Udenfriend, 1956). 
These phenols are highly fluorescent and the quantitative aspects 
of these hydroxylations can be investigated fluorimetrically as 
in the 7-hydroxylation of coumarin (Creaven, Parke and Williams, 
1965b). The 2- and 4-hydroxy biphenyl can be estimated 
fluorimetrically in the same preparation because the 2-isomer 
shows excited state ionization, whereas the 4-isomer does not 
(Bridges, Creaven and Williams, 1965). On the basis of these 
observations, a method for the assay of hydroxylation of biphenyl 
to 2- and 4-hydroxy biphenyl by liver homogenate was originally 
developed by Creaven et^  a]^ , (1965a) , and was modified f or use with 
rats by Neale (1970).
The modified incubation medium used for the present work was 
as follows:
0.05M Tris-HCl buffer PH 8.1 0.50 ml
Magnesium chloride (50ymoles/ml.) 0.20 ml
NADP, 1.5 pmoles in 1.15$ KC1 0.55 ml
Substrate Solution (3 pmoles biphenyl
and 10 mg. Tween 80 in 1.15$ KCl) 0.25 ml
25$ liver homogenate (homogenate at 10,000g) 0.50 ml
Total volume 2.00 ml
The incubation mixture was incubated at 37°C in a shaking water 
bath for 20 minutes* The hydroxylation reaction was stopped? by 
adding 0.5 ml. 2N HC1 while in ice-cold water. The incubation 
mixture in each tube was extracted with 10.0 ml. of n-heptane on 
a rotary shaker for 5 minutes. 2.0 ml. of the upper organic 
layer containing the extracted phenols from each tube was 
pipetted into corresponding tubes containing 10.0 ml. 0.1N NaOH.
The tubes were shaken on a rotary shaker for 5 minutes and then 
centrifuged for 10 minutes at 2000 r.p.m. (M.S.E. Magnum). After 
removing the organic layer from each tube by suction with a Pasteur 
pipette, 2.0 ml of the NaOH layer was pipetted from each tube into 
a cuvette and brought to pH 5.5 (at which 2- and 4-hydroxy biphenyl 
are stable) with 0.5 ml of 0.5N succinic acid. Fluorescence 
intensity was then determined at two wavelengths: (a) at 338 nm 
with excitation at 280 nm and (b) at 415 nm with excitation at 
290 nm.
From reading (a) 4-hydroxybiphenyl was determined directly 
since the 2-isomer does not interfere at this wavelength. From 
reading (b) 2-hydroxybiphenyl was determined after making a 
correction for the contribution of the 4-isomer at this wavelength# 
This contribution was appreciable at low concentrations of 
2-hydroxybiphenyl•
All tubes were prepared in duplicate. A blank was prepared 
by adding the substrate after incubation. Standards were 
prepared by the same procedure adding both substrate and known 
amounts of 2- and 4-hydroxybiphenyl solutions after incubation.
b. In urine
1 ml. urine was heated with 1 ml. conc. HC1 in a boiling water 
bath for 30 min., and then extracted with 10 ml. heptane. 2 ml.
of the heptane layer, containing the hydroxybiphenyls, was removed 
and extracted with 10 ml. 0.1N NaOH. Hydroxybiphenyls were 
measured as described for the in vitro studies.
(iii) Determination of the reduction of p-nitrobenzoic acid
C02H
NO
Liver enzyme 
NADPHg >
>-ni trobenzoic 
acid
NHOH
>
Unstable intermediates p-aminobenzoic
acid
The nitro reductase activity of liver homogenate was measured 
by following the reduction of p-nitrobenzoic acid to p-aminobenzoic 
acid according to the method developed by Fouts and Brodie (1957). 
The incubation medium used was as follows:
Substrate solution in Tris buffer (0.83£gm 
of p-nitrobenzoic acid in 500 ml. of 0.05M 
Tris-HCl buffer, pH 7.62)
Magnesium chloride solution (50pnoles/ml.)
NADP, 0.25 \mole in 1.15$ KC1
G-6-P, 0.25 pinole in 1.15$ KC1
FMN, 0.125 pmole in 1.15$ KC1
25$ liver homogenate (homogenate at 10,000g)
2.0 ml 
0.5 ml 
0.5 ml 
0.5 ml 
0.5 ml
1.0 ml
Total volume 5.0 ml
To create anaerobic conditions the tubes containing the
incubation mixture were flushed with a continuous flow of
nitrogen for 10 minutes whilst keeping them in ice. The tubes
were incubated under the nitrogen flow in a shaking water
bath at 37° C for 30 minutes. The reactions were terminated
by plunging the tubes into ice, opening to the atmosphere and
adding 1*0 ml. of 25$ TCA. All tubes were then centrifuged
at 3000 r.p.m. for 10 minutes at 4°C (M.S.E., Magnum). 4 ml.
of the supernatant was taken and used in the Bratton and Marshall
(1939) test as follows: 0.5 ml. of 0.1$ sodium nitrite was added
and mixed using a ’Whirlimixer'. After 3 minutes 0.5 ml. of
✓
0.5$ ammonium sulphamate was added and mixed. After 3 minutes
0.5 ml. of 0.1$N.E.D. (N—1—Naphthylethylene diamine dihydrochloride
was added and mixed. The total volume was made up to 10ml with distilled
water and allowed to stand for 30 minutes before reading at 545 nm
in a Unicam SP 500.
All tubes were prepared in duplicate. A blank was prepared 
by adding the substrate after incubation, while standards were 
prepared in a similar procedure by adding both substrate and 
standard solutions of p-aminobenzoic acid after incubation. The 
standard curve for p-aminobenzoic acid is shown in Fig. 2.1.
(iv) Determination of 4-methyl umbelliferone glucuronyl transferase 
Many substrates have been used for determining the activity of 
glucuronyl transferase in various tissues. The most common ones are 
o-aminophenol, p-nitrophenol and phenolphthalein (Dutton, 1966).
All these procedures are based on colorimetric determinations either 
of the amount of product formed, or of the decrease in the amount
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Fig. 2.2 Standard curve for the determination of 
4-methylumbelliferone glucuronide.
of substrate. The assay of glucuronyl transferase using 4-methyl 
umbelliferone as substrate is, however, based on fluorimetry, a far 
more sensitive procedure than colorimetry, and this method has been 
used by several workers working with different tissues (Arias, 1962 
- human liver; Taketa, 1962 - mouse liver; Bollet, 1959 - rat stomach 
mucosa). Since this method is more sensitive for glucuronyl 
transferase activity in tissues it has been used to investigate the 
activity of this enzyme with liver preparations.
The method used was essentially similar to that developed by 
Arias (1962) for human liver, but with slight modifications, and is 
based on the fact that 4-methyl umbelliferone is highly fluorescent.
After initially incubating 4-*methyl umbelliferone 'with uridine diphosphate 
glucuronic acid (UDPGA) and liver homogenate, the mixture is extracted 
with chloroform to denature protein and to extract the unconjugated 
4-CHg umbelliferone without removing the glucuronide formed in the 
incubation. This chloroform extract is discarded, 4-CHg umbelliferone 
is then set free from its conjugate by further incubation of the aqueous 
mixture with {3-glucuronidase (Mead et al_, 1955) and the subsequent 
increase in fluorescence is taken as a measure of the glucuronyl 
transferase activity of the liver. It. was reported by Dutton (1966) 
that rat liver has a high requirement for UDPGA in in vitro 
determinations of glucuronyl transferase activity because of the rapid 
breakdown of the co-enzyme by pyrophosphatase activity. These higher 
amounts of UDPGA were added to the incubation mixture.
The incubation mixture used was as follows:
0.1M Tris buffer p H 7.6 0.3 ml
4-CHg umbelliferone, 0.6 pmole 0.3 ml
UDPGA, 2 pmole 0.2 ml
25$ liver homogenate (homogenate at 10,000g) 0.2 ml
(diluted 1 in 20)---------------------- --------
Total value 1,0 ml
After incubation for 30 minutes at 37°C, free substrate was 
extracted and protein was denatured twice in 10 ml chloroform, 
shaking mechanically for 5 minutes each time# 0.5 ml aliquots '
of extracted reaction mixture was incubated for,another 30 minutes 
at 37°C with 0#5 ml {3-glucuronidase (500 units) and 1.0 ml acetate 
buffer (pH 4.6). Other 0.5 ml aliquots of extracted reaction 
mixture was also incubated with 1.0 ml acetate buffer (pH 4.6), 
but without {3-glucuronidase, 5.0 ml of 0.5M glycine buffer (pH
10.4) was added to all tubes after incubation, and the fluorescence 
estimated at 450 nm with an activating maximum of 368 nm.
The blank fluorescence was determined in similar aliquots 
carried through the same procedure but without the {3-glucuronidase.
The increase in fluorescence following incubation with {3-glucuronidase 
was considered to represent the amount of 4-CHQumbelliferone which
O
had been conjugated with glucuronic acid in the first incubation.
Known amounts of d-CH^ umbelliferone glucuronide were run through the 
same procedure and used as fluorimetric standards. Duplicate tubes 
were used in each case. A standard curve for 4-methylumbelliferone 
glucuronide is shown in Fig.2.2.
(v) Determination of cytochrome P-450
The method used for the estimation of cytochrome P-450 was 
essentially that described by Sladek and Mannering (1966). The 
microsomal suspension (3.0 ml) was diluted by adding 6.0 ml of 0.2M 
phosphate buffer, pH 7.4, a few crystals of sodium dithionite were 
added to reduce the haemoproteins present. After mixing by inversion 
2 or 3 times, 3.0 ml of the mixture was taken in each of two cuvettes, 
and carbon monoxide was bubbled through one (the sample) for 30 seconds. 
The second cuvette was used as reference. The difference in the spectra 
between the two was then determined between 550 and 400 nm using a
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dual beam lye-Uni cam SP 800 spectrophotometer# The cytochrome P-450
was taken to be proportional to the absorbance at 450 nm less the
absorbance at 490 nm, and the cytochrome P—450 content was calculated
-1 -1
using the molar extinction of 91 cm mM as determined by Omura and 
Sato (1964)# A typical trace is presented in Fig. 2.3.
(vi) Determination of cytochrome b^.
The method used for determination of cytochrome bg was that
described by Schenkman, Fray, Remmer and Estabrook (1967). The
microsomal suspension (3.0 ml) was diluted by adding 6.0 ml of 0.2M
phosphate buffer, pH 7.4. After mixing, 3.0 ml of the mixture was
taken in each of the two cuvettes, and 10 pi of 2$ NADHg was added to one
(the sample). The second cuvette was used as reference. The difference m  the
spectra between the oxidised and reduced microsomes was then traced at
a wavelength between 500 - 400 nm. in a Unicam SP 800 recording
spectrophotometer, and the difference in absorbance between 424 and
410 nm was measured and the cytochrome b ' content was calculated usingo
—1 —1an extinction coefficient increment (E424-410 nm) of 185 cm” mM •
A typical trace is presented in Fig. 2.4.
(vii) Determination of protein
Microsomal and total liver protein were determined by the method 
of Lowry, Rosebrough, Farr and Randall (1951). A suitable dilution
of the resuspended microsomes and fresh liver homogenate was prepared 
(25$ liver homogenate x 400 and microsomal suspension x 80). To 1 ml 
aliquots of these solutions 10 ml of freshly prepared reagent (100 parts 
2$ NagCO
potassium tartrate) was added and mixed. After at least 10 minutes 
0.5 ml of Folin-Ciojalteaureagent was added and immediately mixed.
After incubation for 30 minutes at room temperature the developed colour
„ in 0.IN NaOH, 1 part 1$ CuSO .5Ho0 and 1 part 2$ sodium 
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was measured at 750 nm using an SP 500. A reagent "blank with water 
and standards of bovine serum albumin were also run through the same 
procedure. The standard curve for albumin is shown in Fig* 2.5.
(viii) Determination of DNA
DNA was separated from a sample of liver according to the method 
described by Zamenhof, Burs ztyn,Rich and Zamenhof (1964). 1.0 ml
of 25$ liver homogenate was extracted with 6$ ice-cold HCIO^ and 
centrifuged in the cold for 10 minutes to remove acid soluble nucleotide 
fractions. The sediment was resuspended twice in ice-cold 95$ ethanol 
and centrifuged for 10 minutes each time to remove lipids. The sediment 
was then suspended in 6.0 ml of 6$ HCIO^ and heated for 15 minutes at 
90°C. After centrifugation for 10 minutes, the sediment was treated 
with another 4.0 ml of 6$ HC10^ and centrifuged again. The combined 
supernatants of the last two steps were used for the colorimetric 
determination of DNA by the modified diphenylamine reaction described 
by Burton (1956): 2.0 ml of diphenylamine reagent (l.5g of recrystallised 
diphenyl amine + 100 ml Analar acetic acid + 1.5 ml conc. F^SO^ + 0*5 ml 
acetaldehyde) was added to 1.0 ml of DNA extract. After incubation 
for 45 hours at 30°C, the developed colour was measured at 600 nm* 
using an SP 500. A reagent blank with 0.5N IIC10^ and standard with 
calf thymus DNA* were also run through the same procedure. Standard 
curve for DNA is shown in Fig. 2.6.
* A stock solution of standard was prepared by dissolving 0.4 mg of calf 
thymus DNA in 5 mM NaOH. From this, working standards were prepared 
every three weeks by mixing a measured column of the stock standard 
with an equal volume of N-HCl0^ and heating at 70° for 15 minutes.
(ix) Determination of phospholipid P.
The phospholipid P in liver was measured by the method described 
by Ring (1932). 0.5 g of liver tissue was extracted with 10 ml of.
methano 1-chloroform mixture (1:2 v/v) and the mixture filtered. 1.0 ml 
of the filtrate was pipetted into a micro-digestion flask and evaporated 
to dryness under nitrogen. 1*0 ml 50$ HClO^ was added and the contents 
of the flask heated at a temperature not more than 60°C , on an 
electric heater until the solution became clear. The cooled contents 
of the flask were washed into a graduated test tube with distilled water 
and the final volume made up to 10 ml. To 4.0 ml of the diluted digest
1.5 ml 0.6$ ammonium molybdate (in 5$ HC10 ) and 0.5 ml freshly prepared 
0.2fo ascorbic acid were added and mixed thoroughly. After incubation 
for 30 minutes at room temperature the developed colour was measured at 
720 nm. using an SP 500. A reagent blank with 5$ HC10. and standards of
T
potassium dihydrogen phosphate* were also run. Standard curve for P i s  
shown in Fig. 2.7.
*A stock solution of standard was made by dissolving 2.1935 g. of pure 
potassium dihydrogen phosphate in 500 ml. of water. This solution 
contained 1.0 mg P per ml.
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(x) Determination of total plasma 11-hydroxycorticosteroid. levels
The 11-hydroxycorticosteroid (cortisol) in rat's plasma was 
measured by the modified method described by Mattingly (1962)*
Cortisol was extracted from plasma by shaking with methylene 
chloride. The extract was mixed with a sulphuric ethanol mixture 
(7:3, v/v; fluorescence reagent) to develop the fluorescence 
^ext 475 nm 515 nm. The fluorescent product is unstable
and therefore the timing of the fluorescence reading was important.
The assay procedure for 11-hydroxycorticosteroid was as follows:
0.5 ml. of heparinized plasma was pipetted into a glass stoppered tube. 
0.5 ml. of distilled water and 4.0 ml. of purified, methylene chloride 
was added, and then mixed by using a rotary shaker for 10 min. 3.0 ml 
of methylene chloride extract was carefully transferred to 5 ml. glass* 
stoppered tube, and then 1.5 ml. of fluorescence reagent was added 
noting the time of addition, and mixed by vigorous shaking for 30 secs. 
The acid layer (lower) was transferred to a fluorimeter cell and the 
fluorescence was measured exactly 25 min. after the fluorescence reagent 
was' added. All tubes were prepared in duplicate. A blank using 
0.5 ml of distilled water and a standard (corticosterone in ethyl 
alcohol) were prepared and run through the same procedure. The 
standard curve for cortisol is shown in Fig. 2*8.
B. .ANIMALS AND DIETS
1. Animals
Wistar albino rats were used throughout. Both sexes were 
used up to 21 days of age when the rats were weaned, and after 
21 days, only males were used. These rats originated from the 
Medical Research Council Laboratory Animal House, and have been 
randomly bred for about 25 generations in the University Animal 
House under normal lighting and heating conditions. The rats 
were all free from specific pathogens. The mother rats were 
littered on hard wood chippings and the young reared to weaning 
(3 weeks) on the same bedding in polyethylene cages with zinc 
plated tops (North Kent Plastics Ltd.) before being transferred 
and maintained in similar cages on ’steralite' bedding (U.P*
Usher Ltd.). More details of animals and caging systems have 
been mentioned elsewhere in this thesis#
2 * Experimental diets
Stock diet (Spillers, 21^ protein) in pellet form was fed to 
the control weanling rats unless otherwise stated. The low (7$) 
protein diet was made from the same stock diet in powder form by 
diluting it with potato starch. Extra amounts of minerals, 
vitamins and fat were added to the low protein diet in order to 
restore their concentrations to approximately the same level as 
those in the original stock diet. The composition of the stock 
and the Tfo protein diets are shown in Tables 2.1 and 2.2 respectively 
The compositions of the vitamin mixture (Cooper Nutrition Products, 
Essex) and the mineral mixture (Nutritional Laboratories, Cambridge) 
used are also shown in Tables 2.3 and 2.4 respectively. More details 
of experimental diets are mentioned in appropriate places in the text
Table 2.1
Composition of
Moisture
Oil
Protein
Fibre
Ash
Calcium 
Phosphorus 
Vitamin A 
Vitamin Dg 
Choline 
Tocopherol 
Thiamine 
Riboflavin 
Nicotinic acid 
Vitamin B ^  
Folic acid 
Iron
the stock (Spillers) diet 
8.5$
5.1$ in the pellet diet(2.0$ in the
powder diet)
21$
2.7$
5.1$
0.9$
0.8$
11.0 I.U./g.
2.4 I.U./g.
520 mg/g.
24 mg/g. ,
4 mg/g.
7 mg/g.
80 mg/g.
0.015 mg/g.
0.16 mg/g.
140 p.p.m.
Starch accounted for the rest of the percentage of 
the ingredients.
Table 2.2
Table 2.3
Composition of the 7$ protein diet
Spillers powder (21$ protein) 33.3
Starch (from potato) 59.3
Vitamin mixture 3.3
Mineral mixture 2.6
Corn oil 1,3
Composition of the vitamin mixture
content/kg
Vitamin A 1,000,000 I.U's
Vitamin D 100,000 I.U's
Vitamin E 10.0 gms
Vitamin B^ 1.0 gm
Nicotinic acid 4.0 gms
Calcium pantothenate 3.0 gms
Folic acid 0,1 gm
Vitamin C 40.0 gms
Inositol 10.0 gms
Vitamin Bg 1.0 gm
Vitamin B^ 1,0 gm
Biotin 0.02 gm
Vitamin B ^  2.0 mgs
Choline chloride 100.0 gms
The base of this supplement was dextrose.
Table 2.4
Composition of the mineral mixture
Gm
Sodium chloride 50
Calcium phosphate 400
Iron citrate 35
Potassium iodide •* 1
Magnesium sulphate 80
Acid sodium phosphate 105
Potassium chloride 250
Sodium fluoride 0.04
Manganese sulphate 0,20
CHAPTER III 
Effect of Development
ANIMAL AND DIETS
Rats were maintained on a stock pellet diet (Table 2*1), and 
water ad lib except where otherwise stated# Pregnant animals were 
separated from the stock and caged individually. Two experiments 
were performed. In the first experiment, litter size was maintained 
at three pups throughout the suckling period. These animals were 
the controls for another experiment (see Chapter IV). Animals were 
weaned at 21 days, separated by sex, and maintained in groups of six
to eight animals. Up to 21 days of age animals of both sexes were
used, but after 21 days males only were used. In the second experiment, 
pregnant rats were reared throughout pregnancy on a synthetic diet 
containing 21$ casein, 60$ starch, 5$ vitamin mixture (Table 2.3),
4$ mineral mixture (Table 2.4) and 10$ corn oil. Litters were 
adjusted,to eight pups at birth and the young were weaned at 21 days 
of age to the same diet as that given to the mother.
In the first experiment, animals were weighed and killed at 
intervals between 6 and 100 days of age, and in the second one at
intervals between 12 and 52 days of age.
ENZYME INDUCTION
The administration of phenobarbital to rats results in an 
elevation of the activity of the hepatic microsomal drug-metabolizing 
enzymes (Remmer and Merker, 1965). Hence, other 12, 21 and 52 days 
old animals reared as described above, were treated with sodium 
phenobarbitone (10 mg/kg body weight) intraperitoneally for three 
successive days and killed 24 hours after the Iasi dose.
EFFECT OF TREATMENT WITH TRITON X-lOO
In order to ensure that the biphenyl 2-hydroxylase and the 
biphenyl 4"hydroxylase were liberated completely from membrane sites, 
further experiments were performed with the addition of vaiying 
concentrations of Triton X-100 to the 10,000 g supernatant of the 
liver homogenates and also to the resuspended microsomal preparations.
The incubation medium used for the microsomal suspension was fortified 
by the addition of an NADPH-generating system: glucose-6-phosphate 
(10 ymole in 0,2 ml) and glucose-6-phosphate dehydrogenase (1,0 unit 
in 0,1 ml).
RESULTS
Effect of growth on liver weight and the activity of drug—metabolizing 
enzymes
Table 3.1 shows that the liver weight rose rapidly to 70 days of 
age and showed no change after 85 days. The body weight, however, 
continued to rise slowly between 85 and 100 days. The liver weight 
relative to body weight rose gradually from 12 days of age to a peak 
value of 4.6$ at 38 days, after which it slowly declined to 3,6$ at 
100 days. The absolute amount of liver protein increased progressively 
until the age of 70 days and thereafter it remained more or less constant. 
Total microsomal protein followed a similar pattern of development with 
age. The progressive increase of the absolute amount of DNA, however, 
continued until 85 days before it slowed down. The activity of 
4-methyl umbelliferone glucuronyl transferase expressed per g. liver 
weight, per 100 g body weight and per unit of DNA attained a maximum 
value at 24 days, and subsequently declined to about 50$ of this value 
at 52 days (see Fig. 3.1).
/-“S /'-V
rH© © © CO © © CM CM rH rH
© ©  • % • • © 00 % © • • •
00 00 rH © • © • t" 'CM CO © CM rH
00 CO, rH *4 ©, rH rH, rH © rH,
CO
vii
4-1 vjj +  1 s±J
©
d
d
d
•H T )
CD s«<^
■P
O CO d
d rH p5
d d O
8 rd
d •rH CO
<0 d
i> d CO
•rH d
rH d
O d
*■ a
-P d
& d «H
fcl © o
•H 3
<D d CO
£ d d
o
d d •rH
<D rd -P
P> 43» d
•H
rH d P»
O d
r «H ©
+3
rd CO ©
fcl d d
•H d d
O d ©
;£ S d
d
d +3
© d CO
o d
rO
CO •
d d
o d
rH o
<d d rd
fc£ > CO
d
«H
o
-p
o
d
«H
d
d
,d
EH
©t-
CM
lO
00co
©
rH
cm
CM
©
©
00
CO
©
*
rH
rH
*
00 ©  
rH
© rH rH rH rH © CM © 'oo*
• • - • 00 • rH © 00 © • • •00 © CO • rH • 00 © rH CM CM CM
CM
CO
CM 
+  1
rH
?J
rH
^+1
n. 
+  1 V_/
©
x
© © CO o © rH
©  
©  * © CO
* • • tH • © rH 00 rH %
rH 00 C5 • rH • rH © © CD
rH
CM ?!
tH
v±J
rH rH
v±J
CO
+
© rH
©
00
o
t r
rH
©
+1
CM CM
CM 
+ 1
©  ©
co, + 1
©
©
©
rH
©
CM
©
tH
CM
t—O
?i
rH
?!
rH
©
CO
+1
©o
+1
©  
♦
Tf* O H 
+1
o
©
CM
CM
+!
CM
O
O
r-
©
+1
rH 
© . 
+ 1
00 © ©
CO
rH O
/*s
©
• rH
• • © • © • © fc- © •
CO rH, • ©, • O, rH “H, © rH,
CO +  \ rH + 1 © , + ) rH vi- +  1
• CM 
rH •
rH 00 
+ 1
©
©© © © rH © CD © • © © ■
• • • © • © © © © • • ©
©
CM
rH
rH
rH,
v±i
© •
?l
rH •
?!
00 ©
X 1
rH ©
X'
o
©
•
©,
^+J
©
CO
'co
©
/— V 
©
. • © 00
• rH • © © © • •
© - • ©, 00 ©. CM ©, ©
+1
>— <
rH ^+J © + rH 4-1 rH
©
rH
CM
©
rH
1)
rH
CM, 
+ 1
©
?!
CM, 
+ 1
CM
© rH rH
CM
O ©
/'-s 
©  
•, O © ©
• % 00 -• © . • © rH • • ♦ ■ •
h- CM. • o, • ©, © ■H CM lO o,
CM 4-J © © ■vii
rH ^+j CM
© *rH
CO
rH
/Hr^ d
CO a
•H
d d
© d
«H
o
d •
hC o
<
CM rH 
• •
CO ©  
•H +1
fcD
&
O
pq
rH
rH
-P
£
d
o
>
3
+1
© ©
rH
% ©
CM
• ©
CM
•
• CO © • o, • o.
©
sii w J
00 4-1 CM -JtJ
rH
*
i •~P
u
%
d
p> ©
•H o
pq
d
•rH
d
-P ^  
O d 
d 0) 
PH f>
•rH
rH rH
d
-P fcD
o aEH S—
d U
g o
o d p»
CO «H *H 
O d rH
d - P \  o o fcfl 
H d 3 3 tv—"
'u
d
P>
•H
rH
fcD
ja.
«
•H
S
©
I
CM
«H
O
OO
PH
(Y^j j° jed'jq/Monrrl) ^TAtq.o^ araAzug
ooCO
o
xo
fcD *HO i-lo *
o
CO
o
CM
o
©
ooo
CM
OO
CO
o
(•qjw. X p o q  *3 001 *ia(^
o
fcD•H
Ph
j o  -qji J 8 A T I  *3 j o 'cI -Jit/'Totml) ^ t a t ^ d b  snuCzng
3#
U#
 
Ef
fe
ct
 
of 
ag
e 
on 
th
e 
ac
ti
vi
ty
 
of 
4-
4n
et
hy
lu
mb
el
li
fe
ro
ne
 
gl
uc
ur
on
yl
tr
an
sf
er
as
e
(TOI J° •ie(I #JETl/loinri)
oo
o
co
o
*
o
CM
o
o
-H
O
05
oo o
o
t>
CO
o10
CO
o
CM
rH
o
00 CO
YV- •- (*q.Ai iCpoq *3 00T 
jod jo *qju. joatx JQd •jqy'xoniri) q^.TATq.0^1 arafzug;
IQ
■ 6*'tJ
Fi
g.
 
3*
2.
 
Ef
fe
ct
 
of 
ag
e 
on 
th
e 
ac
ti
vi
ty
 
of 
p-
ni
tr
ob
en
zo
at
e 
re
du
ct
as
e.
74
(YNG JO *§ni/*xonrriin) 09^“J  0ino.iipoqjCo
cm
-H
©
•H 00 co
~r*
CM
9  e  <3
0 0 4
oo
■H
O
a
o
00
o
o
CO
olO
o
o
CO
p"CM
- o
H
I_
o
CM
OOvH
O
00
o
co
o o
CM
(•qjfc jCpoq *3oOT/*Iorar^ra J0 JeAxp •S/#ionn1iii) 0iuo.iqooq.iCo
«H
O d
•P •
o
•H
O o -P
<y pd a
4? u
«w p
d d
o o
• o
CO Q) d• bD o
CO d o
•
F
i
g
<y
a
od
*d
o
o
to
«HO
0 lO
1P-l
75
io%
CM
'("VNd J° '.iq/Tourri) q^.TATq.0^ einAztig;
}0o
«
CM
O
rH
ID
O
©
©
[05
ooo
o
CO
04
o
u JL X ©
m
&
■4f
xo
CM
o
CM
IO
rH
ID
(#q.A\. -fpoq #Sq0T Ja<^  JQAtx #S jcsd *orq/xoinr1) jfyTATqon ouLfzug; Fi
g.
 
3.
4.
 
Ef
fe
ct
 
of 
ag
e 
on 
th
e 
ac
ti
vi
ty
 
of 
bi
ph
en
yl
14
-h
yd
ro
xy
la
se
.
3T*0~
' ( W d  J° •Sw-J9d/*jii/#xoinri) iCq.TAiq.O'e enuCzua
§ s* •
o o ©
o
o©o
o
o
rd
o
ID
O
o
CO
o<M
O
CM
•H O O
jCpoq *£ OOT «10^ Pn>B 'V*- 
.laATX *§ zed/9jqy'x011^ ) auifztig;
Fi
g.
 
3.
5.
 
Ef
fe
ct
 
of 
ag
e 
on 
th
e 
ac
ti
vi
ty
 
of 
hi
ph
en
yl
 
2-
hy
dr
ox
yl
as
e
The activity of p-nitrobenzoate reductase expressed on all three bases 
of references showed a peak activity at 38 days, which was followed by 
a slow decline to 60$ of this value at 100 days (see Fig. 3*2). Cytochrome 
P-450 followed a similar pattern (see Fig. 3.3) except that the peak 
activity was at 31 days, and this was followed by a sharp fall after 
38 days to an almost mature value. The activity of biphenyl 4-hydroxylase 
showed a maximum at 24 days of age, but unlike p-nitrobenzoate reductase and 
cytochrome P-450 it decreased to 40$ of this maximum value at 85 days 
(see Fig. 3.4). Biphenyl 2-hydroxylase activity was maximal at 21 days 
of age, but unlike the other four enzymes, fell to a negligible value 
at 52 days, and thereafter disappeared completely (see Fig. 3.5).
The ages at which the four enzymes reached peak values are 
summarized in Table 3.2.
Table 3.2 Age at which enzymes reached peak activity
ENZYME AGE (days)
Biphenyl 2-hydroxylase 21
Biphenyl 4-hydroxylase 24
4-methylumbelliferon glucuronyl transferase 24
Cytochrome P-450 31
p-nitrobenzoat,e reductase 38
The percentage induction of enzyme activity by phenobarbital decrs^s;  ^
with age (Table 3.3)# In 12-day old animals the induction was greatest 
for biphenyl 2-hydroxylase and least for p-nitrobenzoate reductase. In 52- 
day old animals, the induction was greatest for biphenyl 4-hydroxylase and 
negligible for p-nitrobenzoate reductase.
Table 3.3. Effect of phenobarbital at three different
ages in the growing rat on the activity of 
liver microsomal enzymes
The rats were treated with phenobarbital (10 mg/kg body wt. intraperitonealdy) 
for 3 successive days 24 hrs. before killing. The results given as means 
(+} standard deviation for at least 6 rats. The figures in the brackets 
indicate the percentage increase in activity caused by phenobarbital.
Pheno­
barbital Age (days)
treatment 12 21 52
Biphenyl
4-hydroxylase 2.6 (+ 0.24) 4.9 (+ 0.03) 3.0 (+ 0.8)
(pmole/g. liver wt/hr) + 6.8 (+ 0.27) 8.0 (+ 1.2) 4.5 (+0.7)
(+ 161$)
C
O
C
D
>
+
,
. (+ 50$)
Biphenyl
2-hydroxylase - 0.15(+ 0.05) 0.30(+ 0.05) o • o !+
" o
(pmole/g. liver wt/hr) + 0.54(+0.12) 0.40 (+ 0.05) 0.05(+ 0)
(+ 260$)
oC
O (+ 25*)'
r ---— -
reductase — 0.42(£ 0.02) 0.90(+ 0.06) 1.2 (+ 0.34)
(pmole/g. liver wt/hr) + 0.67(+ 0.06) 1.06(+ 0.05) 1.3 (+ 0.28)
(+ 60$) 00 (+ 8$)
Cytochrome P-450 - 13.0 (+ 1.0) 23.0 (+ 2.5) 21.0 (+ 4.1)
(m uunolo/g.liver wt.) + 24.0 (+ 1,9) 38#0 (+ 6.0) 27.0 (+ 3.8)
(+ 84$) (+- 65$) (+ 30$)
Effect of Triton X-100 on the activity of liver biphenyl 2- and 4-hydroxylase
It was considered that the loss of activity of biphenyl 2-hydroxylase 
with increasing age might he due to increased binding of this membrane- 
bound enzyme* However, the addition of Triton X-100, a detergent which 
has been used to activate membrane-bound, enzymes (Lueders and Knf f , 1967) 
did not increase the activity of biphenyl 2-hydroxylase (Table 3.4) but 
at a concentration of 10 $  led to a 30^ reduction in the activity of
biphenyl 4-hyd.roxylase.
Table 3*4 Effect of Triton X-100 on the activity
of biphenyl 2- and 4-hydroxylase in the 
liver of 52-day old rats
Triton X-100 
(Cone.)
1c
Biphenyl 4-Hydroxylase 
({jmole/g. liver/hr.)
Biphenyl 2-Hydroxylase 
(jjmole/g. liver/hr.)
0 3.1
1 *
< 0.01
io-3 2.9 < 0.01
io-2 2.8 < 0.01
io"1 2.1 < 0.01
Comparison of synthetic and stock diets
The offspring of pregnant rats which had been fed throughout gestation 
and lactation on the synthetic diet weighed less and grew more slowly than 
the offspring of female rats fed throughout on the stock diet. The liver 
weight relative to body weight of the rats on the synthetic diet, however,
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followed the same pattern as that for those on the stock diet (see Table 3.5) 
Biphenyl 2-hydroxylase showed a consistently higher activity, up to three 
times, in rats fed the synthetic diet even when the enzyme activity was decli 
(Table 3.6). After weaning (18 days) the amount of hepatic cytochrome 
P-450 was lower at all ages in the rats fed the synthetic diet. The
other enzymes showed no significant differences due to diet.
DISCUSSION
The liver was found to grow at a faster rate than the body as a whole 
up to 38 days of age but from 52 days the body weight increased faster 
than the liver weight. Between 70 and 100 days of age the absolute weight 
of the liver remained constant and so did its protein content. The body * 
weight, however, continued to rise to 100 days of age, partly due to 
the accretion of body fat (Miller and Payne, 1962). The nuclei of rat 
liver show polyploidy (Davidson, 1953), but as the rat liver cell with 
a tetraploid nucleus is twice as large as that with a diploid nucleus the 
ratio of cytoplasm to unit weight of DNA remains constant (Epstein, 1967).
It is therefore possible in this case to use DNA for the expression of 
cellular constituents on a unit cell basis (Enesco and Leblond, 1962).
The protein DNA ratio which may be used as a measure of cell size, 
rose steadily to 31 days of age and showed a broad peak between 38 and 
85 days. This suggests that the cells of the liver may be larger during
the period of anabolism due to puberty. The total amount of DNA increases
at different rates in different organs and reaches its adult value at 
different ages and in the ratdfcis considered to reach its adult value in 
the liver at 70 days of age (Winick and Noble, 1965). In the liver of
the rats used in the present experiments, the total amount of liver DNA
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appears to reach its mature value at 85 days of age.
The activity of each enzyme studied when expressed per unit of 
body weight rose to a peak soon after weaning (18-21 days) and then 
decreased with age. This decrease was only partly accounted for by 
the increase in the rate of growth of the body relative to the liver.
In the case of biphenyl 2-hydroxylase, the activity fell rapidly 
after 31 days and disappeared altogether at 70 days. The low level of 
activities of this enzyme were not due to decreased availability of 
enzyme sites through increased association of the enzyme with membranous 
elements of the endoplasmic reticulum for there was no increase of 
activity when the detergent Triton X-100 was added. However, this 
result is not surprising because "Tween 80", another membrane activating 
detergent, is already present in the incubation mixture necessary for the 
determination of this enzyme activity (Creaven et al, 1965). This 
addition of Triton X-100 actually resulted in inhibition of the activity 
of the biphenyl 4-hydroxylase. The reason for the disappearance of the 
activity of biphenyl 2-hydroxylase with increasing age is therefore still 
obscure. The activity of biphenyl 4-hydroxylase in mature rats, on the 
other hand, was about 40$ of the maximum value, and as with all other 
enzyme activities studied with the exception of biphenyl 2-hydroxylase, 
remained constant from 52 days of age
Phenobarbital induced the activity of the microsomal enzymes in 
rats of all ages, but the rate of induction was highest for all enzymes 
studied in the 12 day-old rats. This finding supports the work of 
Kato and Takanaka (1968) who demonstrated that the phenobarbital-induction 
of aminopyrine N-dernethylation, hexobarbital hydroxylation, aniline 
hydroxylation and p-nitrobenzoate reduction was much greater in 40-day
old rats than in older animals# Thus immature rats are intrinsically 
more responsive to enzyme induction.
The activity of biphenyl 2-hydroxylase was not increased at 
52 days of age by the addition of Triton X-100 and treatment with 
phenobarbital failed to induce the enzyme, The induction of 
4-hydroxylation by phenobarbital paralleled to some extent the 
increase in cytochrome P-450, whereas the induction of 
2-hydroxylation at 12 days was greatly in excess of, and at 
21 days was much less than that of biphenyl 4-hydroxylase#
Therefore there would appear to be no correlation between 
2-hydroxylation of biphenyl and cytochrome P-450, although one 
might exist for 4-hydroxylation. Biphenyl 2-hydroxylase is not 
thus likely to be affected via cytochrome P-450, but it is a 
microsomal enzyme and like glucuronyl transferase might be expected 
to exist in different states of association with the endoplasmic 
reticulum and the degree of availability to the substrate. If this 
is so, then biphenyl 2-hydroxylase is far more difficult to elucidate 
than glucuronyl transferase. Parke and Rahman (1970) have shown 
the induction of 2-hydroxylase by safrole and iso-safrole is due 
in part to protein synthesis. It would therefore appear that the 
failure to induce biphenyl 2-hydroxylase activity after 52 days of 
age is probably due to loss of the ability to synthesize this 
particular protein.
CHAPTER IV
Effect of Undernutrition During the 
First Three Weeks of Postnatal Life
ANIMALS AND NUTRITION
Rats were mated and separated from the stock when found to be 
pregnant. In the first experiment litters born on the same day were 
divided into two groups after they were born. In one group three 
pups were put with one lactating mother (small litter) as used in 
developmental studies (see Chapter III), and in the other group, 
fifteen with another lactating mother (large litter) (Widdowson and 
McCance, I960). Pups of the former group were well nourished and served 
as controls for those of the latter group, which were undernourished. 
Litters of control and undernourished pups were killed at 6, 12, 18 and 
21 days respectively,after birth, the livers removed and the enzyme 
concentration in them measured.
ENZYME INDUCTION
Other 12- and 21-day old control and undernourished rats were given . 
phenobarbital as described in Chapter III, in order to determine whether 
any low enzyme activity was due to the inability of the enzyme-synthesizing 
system to be stimulated or to a lack of stimulus.
RESULTS
Liver weight, body weight, DNA and microsomal protein content
Table 4.1 shows that undernutrition during the first three weeks 
of postnatal life resulted in significantly lower liver and body 
weight. As a percentage of the body weight, the liver of the 
undernourished rats was, however, smaller at 6 and 12 days of age, 
but not at 18 and 21 days. The concentration of DNA and microsomal 
protein in the liver of the undernourished rats was the same as in the 
controls, and thus the amount of hepatic DNA and microsomal protein 
per unit of body weight was significantly less in the undernourished
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rats only at 6 and 12 days of age (Table 1.2) and the total liver 
microsomal protein and ENA were considerably reduced at each age 
(Fig. 4.1).
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Fig. 4.1 Effect of underfeeding rats during the first three -week 
of postnatal life on the absolute amount of microsomal 
protein and DNA per whole liver.
The activity of hepatic microsomal drug-metabolizing enzymes
Undernutrition during the first three weeks of postnatal life 
did not change the specific activity of the hepatic microsomal drug-
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metabolizing enzymes, biphenyl 4-hydroxylase, p-nitrobenzoate reductase 
and 4-methyl umbelliferone glucuronyl transferase or the concentration 
of cytochrome P-450 per unit of liver weight. Since the weight of liver 
per 100 g body weight was lower in the undernourished rats at 6 and.12 
days of age than in the controls, the enzyme levels relative to body 
weight were also lower only at these ages (Figs. 4.2, 4.3, 4.4 and 4.5). 
Similarly, since the liver weights were significantly less (Table 4.1) 
and the concentrations of the enzymes in liver did not show any change in 
rats (Figs. 4.2-4.5) undernourished for 6, 12, 18 and 21 days after birth, 
the total liver licrosomal enzymes were considerably depressed in these 
animals (Fig. 4.6).
Effect of phenobarbital treatment on body weight, liver weight, DNA 
and microsomal protein content of the liver and on the activity of 
hepatic microsomal drug-metabolizing enzymes.
Table 4.3 shows that the difference in liver weight relative to body 
weight noted between 12 day old untreated control and undernourished rats, 
disappeared after phenobarbital treatment, and so did the difference in DNA. 
and microsomal protein content of the liver per unit of body weight. The 
activity of microsomal drug-metabolizing enzymes and the level of Cytochrome 
P-450 in the livers of 12-and 21-day old control and undernourished animals, 
were induced by phenobarbital (Table 4.4). Like DNA and microsomal protein 
there was no significant difference in the activity of the enzymes and P-450 
per unit of body weight which appeared to be lower in the untreated 12-day 
old undernourished rats. The percentage of induction of the hepatic 
microsomal drug-metabolizing enzyme activities by phenobarbital treatment 
was, however, higher in the undernourished rats than it was in the controls, 
and the induction was greatest for biphenyl 4-hydroxylase and cytochrome 
P-450 and least for p-nitrobenzoate reductase at 12- and 21-day old 
control,and undernourished animals.
Fig# 4.2. Effect of underfeeding suckling rats
on the activity of biphenyl 4-hydroxylase
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on the activity of cytochrome P-450.
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Table 4.4
Effect of phenobarbital treatment of undernourished 
suckling rats on the activity of microsomal enzymes
Animals were treated with phenobarbital (10 mg/kg body wt.) 
intraperitoneally for three successive days until 24 hours 
before killing. Each result given as the mean +_ standard 
deviation for at least 7 rats. Figures in parenthesis 
indicate the percentage increase in activity caused by 
phenobarbital.
C = control UN = undernourished
Age (days) 12 21
Description UN C UN C
values expressed per g. liver Art.
4-hydroxylase 7.7(+185) 6.9(+165) 8.9(+93) 8.0(+63)
(ymole/hr.) + 0.4 +0.5 + 1.5 + 1.2
1'Titro reductase 0.66(+162) 0.67(+60) 1.00(+43) 1.06(+18)
(pmole/hr.) +0.09 +0.06 +0.11 +0.13
Cytochrome P-450 
(n.mol.)
28.0(+l22)
+3.8
24.0 (+84) 
+ 1.9
42.0(+93)
+7.0
38.0(+63)
+6.0
values expressed per 100 g. body wt.
4-hydroxylase 25.5(+280) 26.0(+205) 33.3(+100) 33.2(+66)
(pmole/hr.) +2.5 + 3.5 +5.5 +4.8
Nitro reductase 2.3 (+130) 2.5(+108) 3.8(+46) 4.3 (+30)
(ymole/hr.) +0.3 +0.4 +0.8 + 0.6
Cytochrome P-450 93(+225) 9l(+13l) 162(+88) 158(+71)
(n.mol.) + 5 + 14 +26 +27
DISCUSSION
Undemutrition during the first three weeks of postnatal 
life restricted the gain in weight of the body and, liver, and 
the liver was restricted more than the body during the first two 
weeks of life. Undernutrition did not affect the INA and 
microsomal protein content of the liver or the activity of 
hepatic microsomal drug-metabolizing enzymes perg.liver at any 
age during the first 21 days of life, the hepatic content of these 
substances per unit of body weight was therefore less only during 
the first two weeks of life* However, the difference in the 
liver weight/body weight ratio found at 12 days disappeared after 
the animals had been given phenobarbital. Thus, from the present 
investigation, it seems clear that undemutrition during the suckling 
period does not result in any true change of the hepatic microsomal 
drug-metabolizing enzymes in terms of concentration per unit of 
body weight, for their activity is restricted in parallel to the 
restriction in growth of the liver.
Phenobarbital induced the activity of the microsomal enzymes 
in rats of all groups, but the rate of induction was highest for 
all the enzymes studied in the undernourished rats. These findings 
support the observations made in the developmental studies (see 
Chapter III) where it was found that younger rats are intrinsically 
more responsive to enzyme induction than older ones.
The first three weeks of postnatal life is the period when the 
activity of the microsomal drug-metabolizing enzymes is in a 
progressively increasing phase (Chapter III). Furthermore, the 
enzyme-synthesizing system in the undernourished animals can be
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Fig# 4*6 Effect- of underfeeding rats during the first 
three weeks of postnatal life on the absolute 
amount of microsomal drug-metabolizing enzymes 
per whole liver#
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stimulated by phenobarbital treatment more than in the control ones. 
Thus it would appear that the hepatic concentration of the enzymes 
in the undernourished suckling rats is maintained at control level, 
possibly due to increased availability of enizyme sites during this 
period of life through decreased association of the enzyme with 
membranous elements of the endoplasmic reticulum. It could therefore 
be that within the limitations of liver size imposed by the under­
nutrition the synthesis of the microsomal enzymes has a high priority.
Phenobarbital induced biphenyl 4-hydroxylase and cytochrome P-450 
to a much greater extent than it did for p-nitrobenzoate reductase 
in both control and undernourished groups during the suckling period 
of life. It would therefore appear to be a correlation between 
4-hydroxylation of biphenyl and level of cytochrome P*-450. A similar 
correlation between cytochrome P-450 and the reduction of p-nitro­
benzoate to p-aminobenzoate has been reported (Gillette et^  al, 1968), 
but this is clearly not supported by the present findings.
CHAPTER V 
Effect of Protein Nutrition
ANIMAL AND DIETS
Rats were reared in litters of eight pups and weaned at 21 days.
At 24 days of age,' males of similar body weight wefe divided randomly 
into four groups. Group A was maintained on the stock diet (Table 2#l) 
containing 21$ protein and served as controls; Group B was fed the 
stock diet diluted to contain 7$ protein by the addition of potato 
starch (Table 2.2); Group C was given the weight of stock diet which 
contained the same amount of protein as that eaten by Group B, i.e.
4 gm stock diet/rat/day in the first week, 5 gm/rat/day in the second 
week and 6 gm/rat/day in the third and fourth weeks. Group D were 
maintained on a protein free diet. All the animals were housed 
individually, and rats from Groups A, B and C were killed after 7, 14 
and 28 days respectively. Rats in Group D were killed after 28 days, 
the livers removed, and the enzyme concentration in them measured.
ENZYME INDUCTION
In order to establish the potentiality of ’protein deficient’ 
animals to stimulate the activity of the hepatic drug-metabolizing 
enzymes further groups of animals fed as described for A, B and C 
respectively, were given the enzyme inducer , sodium phenobarbitone, 
as described in Chapter III, and the enzyme concentration measured 
in the livers after 7 and 28 days on the diets,
INFLUENCE OF CORTICOSTEROIDS
In order fo study the effects of corticosteroids on the activities 
of drug-metabolizing enzymes, other animals fed as described for A, B
and C r e s p e c t i v e l y  were anaethetizecl with ether after 7, 14 and. 28 days 
respectively on the diet. Heparinized blood was collected from the 
hearts of each group of animals. The blood was immediately centrifuged 
and the plasma separated and stored at -40°C. Plasma 11-hydroxy- 
corticosteroids (corticosterone), which are believed to be essential 
for biological activity in rats, were determined, as described in 
Chapter II.
CORTICOSTERONE
In a further experiment, 52-day old control rats were treated with 2 
successive doses at 6-hour intervals of corticosterone (l.O mg/animal, 
subcutaneously), and the animals killed on the following day. The 
activity of biphenyl 4-hydroxylase in the liver of these animals was 
determined and compared with that of the untreated, animals.
IN VIVO METABOLISM OF BIPHENYL
Further groups of animals fed as described for A and B for 28 days, 
were given a dose of biphenyl (25 mg/kg body weight, orally). Urine 
from each of these animals was collected for two periods of 24 hr. after 
the administration of biphenyl, and the metabolite, hydroxybiphenyl 
measured in the urine. This study was necessary to elucidate the point 
as to whether the activity of biphenyl hydroxylase measured in vitro 
has any relevance to the metabolism of biphenyl in vivo.
RESULTS
Body weight, liver weight and DNA content of the liver
Protein deficiency and calorie deficiency resulted in a fall in 
weight gain (Fig. 5.1). The protein-sparing effect of the high calorie 
content of the low protein diet was evident in the 'protein deficient1 
group (Group B) for their body weights were higher than those of the 
'calorie deficient' group (Group C). The percentage of the body weight 
contributed by the liver was similar in both the experimental groups 
and in both was lower than in the controls.
The amount of ENA per liver increased progressively with age in 
the rats in Group A. (Table 5.1). After 7 days on the protein deficient 
diet (Group B) the DNA content of the liver was lower than in the 
controls, and it increased at a slower rate with age.
Table 5.1
Effect of protein nutrition nn DNA content, 
and protein/DNA ratio in rat liver.
Each value is the mean with the standard error 
in parenthesis. For legends see Fig. 5.1.
. Total DNA -^Protein/DNA ratio .
r  (mg.) r  n
Days on diet A B C A B C
7 19.8(0.6) 13.8(1.1) 12.5(0.6) 30(l) 26(l) 25(l)
14 30.3(3.0) 18.0(0.8) 13.3(l.l) 27(2) 25(l) 26(2)
28 41.1(4.0) 22.0(2.3) 16.0(1.0) 35(2) 34(2) 30(2)
The DNA content of the livers of the calorie deficient animals (Group C) 
was not significantly lower than that of the protein deficient animals
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at 7 days but it showed only an insignificant increase with age* The 
protein/DNA ratio was similar in all groups of the same age, but the 
ratio tended to be higher at all periods in Group A.
Hepatic microsomal drug-metabolizing enzymes
Feeding the protein deficient diet with or without additional 
calories for 7 days did not change the activity of biphenyl 4-hydroxylase 
(Table 5*2), but feeding the diet for a further 7 or 21 days increased 
it, and this was true whether the activity was expressed per g. liver 
or per mg of microsomal protein. After 14 and 28 days on the protein 
deficient diet with additional calories, the increase in enzyme activity 
per g liver was sufficient to compensate for the lower liver weight so 
that the absolute amount per liver was the same as in the controls 
(Fig. 5*2). However, this was not true in the ’calorie deficient’ animals 
The activity of biphenyl 4-hydroxylase was induced by phenobarbital at 
7 and 28 days (Table 5.2), regardless of dietary intake, but the pattern 
remained the same. Thus a 7 day period of adaptation was followed by 
an increase in concentration in the ’protein deficient’ animals which 
was again sufficient to raise the total activity per liver to the control 
level (Fig. 5.3).
From the in vivo studies it seemed that the capacity of the body 
to metabolize biphenyl and excrete it as hydroxybiphenyl in urine was also 
similar in control rats, and those fed a protein deficient diet for 
28 days (Table 5.3).
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Table 5*3
Effect of a protein deficient diet fed for 
28 days on .the iri vivo metabolism of biphenyl.
Animals were given biphenyl orally (25 mg/kg 
body weight). Each result is a mean for 4 
animals with standard error +_• For legends 
see Fig. 5.1.
Excretion ox hydroxybiphenyl (jig)
1st 24 hr 
urine
2nd 24 hr. 
urine
Total 48 hr. 
urine
Group A 120 (+ 22) 28(+ 6) 148 (+28)
Group B 154 (+41) 20(4. 6) 177 (+47)
Unlike biphenyl 4-hydroxylase, the specific activity of p-nitro- 
benzoate reductase was increased at all times in the ’calorie deficient’ 
animals as compared with the controls, whereas in the 'protein deficient' , 
animals it was unchanged (Table 5.4). However, after being induced by 
phenobarbital, the specific activity at 7 days reached the same level in 
all three groups, but at 28 days, the 'calorie deficient' and the 'protein 
deficient' groups showed a higher activity and in 'protein deficient' 
animals this was again sufficient to compensate for the lower liver weight 
so that the amount of enzyme per liver in these animals was the same as 
in the controls.
By 28 days, the specific activity of glucuronyl transferase was 
increased in the 'protein deficient' group, but was depressed in the 'calorie 
deficient' animals (Table 5.5).
After a period of 14 days the hepatic concentration of cytochrome P-450 
was decreased (Table 5.6) in the 'protein deficient' group, but remained unchange
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in the ’calorie deficient1 one, The concentration of cytochrome P-450 in 
the ’protein deficient’ group showed a similar pattern of response 
when induced Jbty. phenobarbital, hut in the ’calorie deficient’ 
animals at 28 days it was increased. The activity of NADPH-cytochrome 
£-reductase involved in the earlier part of electron transport chain of 
drug oxidation, was also decreased in the ’protein deficient’ animals 
(Table 5.7). However, cytochrome b^, which is also believed to be 
involved in the electron transport system for drug oxidation, tended to 
be increased by protein deficiency. Feeding a protein-free diet for 
28 days resulted in a drastic fall in body weight and liver weight, 
but despite the severe weight reductions, the specific activity of 
biphenyl 4-hydroxylase was raised in the livers of these animals.
Table 5.7
Effect of protein deficient and protein-free 
diet fed for 28 days on body weight, liver 
weight and activity of liver microsomal drug- 
metabolizing enzymes
Each value is expressed as the mean with standard 
error in parenthesis.
Diet Control Protein Protein-free
(Group A) deficient (Group D)
(Group B)
Initial 63(2) 54(2) 63(l)
Body wt:
Final 247(10) 143(7) 44(l)
Liver wt. 11.3(0.6) 5.2 (0. 3) 1.5(0.05)
* • ♦ < « >  » • « » • * )
p-ni trobenzoate
 reductase 1.0(0.05) 1.5(0.l) 1.0(0.03)
pmol/g.liver/hr.
‘»2<2> •»<*>
Cytochrome b,. 9.l(0.3) 10.4(0.5)
imtol./g. liver
The activity of p-nitrobenzoate reductase, however, was unchanged and 
the concentration of cytochrome P-450 was reduced in these animals*
Kinetic study of biphenyl 4-hydroxylase
The increased concentration of biphenyl 4-hydroxylase in the 
'protein deficient1 group could be due to a conformational change of 
the enzyme site. In order to elucidate this point, it seemed important 
to study the kinetics of the enzyme. However, from a k i n e t i c  study 
of biphenyl 4-hydroxylase (Fig. 5.4) it seemed that the V ay was higher 
in the 'protoin deficient' and 'calorie deficient' groups than it was 
in the controls, but values remained unchanged.
Plasma corticosteroid level
In the 'protein deficient' group the plasma level of 11-hydroxy- 
corticosteroids was unchanged after 7 days on the diet, but from 14 days 
onwards it had increased about three-fold (Table 5.8). The 'calorie 
deficient' animals, however, responded more quickly to the diet for the 
plasma corticosteroid level was found to be high at 7 and 14 days. By 28 days 
on the calorie deficient diet, the level had greatly decreased.
Table 5.8 Effect of protein nutrition on the plasma level
of 11-hydroxycorticosteroids
C = control PD = 'protein deficient' CD = 'calorie deficient'
Each group consisted of at least 6 rats.
The values are means +_ standard error.
Days on diet-------------- j-----7   ^ j—---14 . j * 28------j
Diet C PD CD C PD CD C PD CD
11-hydroxy-
corticosteroids 28 28 46 18 48 40 17 53 10
(pg/100 ml plasma) . +2 +6 +6 +2 +6 +4 +3 +4 +2
X(* Jq/* ati •S/aioui'rt)
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Effect of corticosterone administration on the liver aromatic hydroxylase
activity in normal rats
Treatment of control rats with corticosterone resulted in a 
considerable increase in liver weight, a small, but significant (P< 0*05), 
increase in the activity of biphenyl 4-hydroxylase per mg of microsomal 
protein and a considerable increase in the total activity per liver
(Table 5.9).
Table 5.9
Effect of corticosterone on liver weight 
and activity of biphenyl 4-hydroxylase
Rats were treated with 2 successive doses of 
corticosterone (10 mg/animal subeutaneously)at 6 hr. 
interval. Each result given as the mean + standard 
error for at least 4 rats.
Control + Corticosterone
8i0 14.0
+0.7 +0.9
Biphenyl 4-hydroxylase
pmo 1 /mg microsoma 1 protein/hr. 0.15 + 0.02 0.19 + 0.01
pmol/liver/hr. 27.5 + 2.5 51.3 jh 5.0
DISCUSSION
In rats fed a normal diet, the growth of the liver during the first 
month after weaning is characterized by a rapid increase of DNA content.
In contrast, the livers of animals whose growth was retarded by feeding 
a protein deficient diet, with or without additional calories, showed 
only a slight increase in DNA content. The hepatic concentration of 
drug-metabolizing enzymes and cytochrome b^, though not of NADPII-cytochrome
Liver weight
c-reductase and cytochrome P-450, however, appeared to be either unchanged 
or increased by feeding a protein deficient diet with additional calories 
for 14 or more days# The increase of these enzymes seems, therefore, 
to be independent of changes in the DNA content.
After a lag period of 7 days, the total activity of biphenyl 
4-hydroxylase per liver in the protein deficient group was the same as 
in the controls. However, this was not true in the ’calorie deficient1 :  ^
animals in which not only was the specific activity lower than in the 
'protein deficient' animals, but the liver also weighed less. Phenobarbital 
acts as an inducer of drug-metabolizing enzymes in the liver, and its adrainisismdaon 
showed that the lower activity of biphenyl 4-hydroxylase in the 'calorie 
deficient' group was not due to a lack of stimulation,e.g. enzyme substrate, 
but to a lack of calories and/or protein necessary for enzyme synthesis.
The capacity of the body to metabolize biphenyl and excrete it as hydroxy 
biphenyl intheurine was similar in control rats and those fed a protein 
deficient diet for 28 days. Thus Hie in vivo metabolism of biphenyl 
appeared to be parallel to the activity of biphenyl hydroxylase measured 
in vitro. The hepatic concentration of p-nitrobenzoate reductase, on the 
other hand, was higher in the 'calorie deficient' animals than in the 
'protein deficient' ones. Phenobarbital treatment resulted in a 
higher concentration of this enzyme in the protein deficient animals 
than in the calorie deficient ones, and thus the lower activity of this 
enzyme in the protein deficient animals appeared to be due to lack of 
stimulation. The concentration of cytochrome P-450 was depressed after 
_28 days by a protein deficient diet but not by a deficiency of total 
calories»
The results of the present studies therefore show that the 
drug-metabolizing enzymes and cytochrome P-450 respond in different 
ways to a deficiency of protein with or without additional calories#
Thus, biphenyl 4-hydroxylase and glucuronyl transferase are 
susceptible to a deficiency of total calories rather than specifically 
of protein, whereas, p-nitrobenzoate reductase and cytochrome P-450 
are susceptible to the amount of protein in the diet independent of 
calories# These observations are in agreement with those for a 
variety of other hepatic enzymes, the specific activity of some 
being increased and others decreased or unchanged by a protein deficient 
diet (Waterlow, 1960; Y/oodcock and Wood? 1971)#.
However, since in the protein deficient animals, the hepatic 
cytochrome P-450 was diminished (Table 5.6) and the for the biphenyl 
4-hydroxylase was unchanged but the increased (Fig# 5.4) , the
increased hepatic biphenyl 4-hydroxylase activity (Table 5.2) is unlikely 
to be due to any change of the active sites or in the total amount of 
the terminal oxygenase. It is more likely to be due to.an increase of 
some other component of the associated electron transport chain, particularly 
cytochrome b^ which tended to be higher in the ’protein deficient' animals 
(Table 5.7) or perhaps P-450 reductase, or to some conformational change 
of the membrane of the endoplasmic reticulum or change of membrane 
environment. However, increase of the biphenyl 4—hydroxylase per unit microsomal 
protein may account for the preferential utilization of the amino acids 
for the synthesis of this protein, and thus it could be that surviving 
protein synthesizing sites may be relatively more 'active' in 'protein 
deficient' animals. Surviving sites have been found to have relatively 
heavier polysomes and. fewer monosomes and oligosomes (Fillios, 1970)
a situation which can account for the higher specific activities suggesting 
a greater protein synthesis at the remaining sites (Kuff and Roberts, 1967). 
An increase in specific activity, therefore, does not necessarily mean an 
increase in total activities. In other words, the reduction of total protein 
in the liver is not merely a reflection of synthesis and turnover of proteins 
but also of available sites.
Corticosteroids have been implicated in the adaptations of protein 
synthesis that occur in response to a protein deficient diet (Y7aterlow,
1968). From the present investigations it seems that in the 'protein ' 
deficient1 animal, the plasma 11-hydroxycorticosteroids followed a 
similar pattern to the hepatic concentration of biphenyl 4-hydroxylase 
(Table 5.8). In the calorie deficient animals, however, the plasma 
corticosteroid level responded to the diet by 7 days, but the aromatic 
hydroxylase activity per g. liver weight did not appear to be altered 
at this time. It may be supposed that this lack of effect was due to 
the deficiency of calories which necessitated the utilization of some 
dietary protein as a calorie source. However, the high plasma level
<•* ‘ -v’i ’ .
of corticosteroids persisted for a further 7 days and by this time had 
evidently effected some change in the pattern of protein synthesis for 
the level of the enzyme was increased (Table 5.2). The increase in 
enzyme activity was maintained to 28 days but by this time the plasma 
corticosteroid level had greatly decreased (Table 5.8), possibly due 
to the lowering of the plasma cholesterol level and the depletion of 
liposomes, the precursors of corticosteroids (Bondy, 1969).
The simultaneous increase in plasma corticosteroids and the 
stimulating effect of these hormones (Table 5.9) might suggest that the 
increases observed in the hepatic aromatic hydroxylase activity were 
mediated either directly or indirectly through the endogenous steroid 
hormones.
CHAPTER VI
Effect of Various Dietary Carbohydrates
MATERIALS AND METHODS
Animals of similar body weight were divided at 24 days of age 
into five groups of 10# Group A was maintained on a diet containing 
60$ starch, and Groups B, C, D and E on diets that were similar in 
every respect, i,e# protein, fat, minerals and vitamins, except that 
the starch was replaced by sucrose, glucose, fructose, and an equimolar 
mixture of glucose and fructose respectively (Table 6#l).
Table 6.1 COMPOSITION OF DIETS
(g./lOO g,.diet])
STARCH SUCROSE 
(Group A) (Group B)
GLUCOSE 
(Group C)
FRUCTOSE 
(Group D)
GLUCOSE 
and ‘ 
FRUCTOSE 
(Group E)
Starch 60
Sucrose 60
Glucose 60 30
Fructose 60 30
Casein 21 21 21 21 21
Corn oil 10 10 10 10 10
Mine rals 4 4 4 4 4
Vitamins 5 5 5 5 5
In order to elucidate the degree of potentiality of the microsomal 
enzymes being induced, a second experiment was performed in which five 
animals on each of the five dietary regimes were given a dose of 100 mg/kg. 
body weight of the enzyme inducer, sodium phenobarbitone, intraperitoneally 
24 hours before killing. These animals will be referred to throughout
as the 'treated' rats compared with the 'untreated' ones in the first 
experiment. All the animals in these two experiments were killed by- 
decapitation after 14 days on the diet. The liver was quickly removed 
weighed and the activities of the microsomal enzymes, cytochrome P-450 
INA, protein and phospholipid phosphorus measured according to the 
methods described in Chapter II.
Since it could reasonably be objected that a diet containing 60$ 
sucrose is very abnormal for a rat and has little relationship to the 
content of sugar in the normal human diet, a third experiment was 
performed in which a diet containing only 10$ sucrose was fed to a 
group of six weanling rats (25 days old) for 25 days and these rats 
were compared with the adult rats (100 days old} fed a diet containing 
10$ sucrose for 100 days. These animals were killed and treated as 
before. . •
In order to compare the effect of dietary sucrose on the drug- 
metabolizing enzymes of growing rats with that of other disaccharides, 
a further experiment was performed in which two groups, each of five 
rats, were fed a diet containing either 60$ lactose or 60$ maltose, 
for 14 days. These animals were given the same amounts of protein, 
minerals, vitamins and fats as those in the other experiments (Table 6
RESULTS
(a) Effects of diets containing starch, sucrose, and its constituent 
monosaccharides
(i) Growth, weight of liver and the activity of drug-metabolizing 
enzymes
'Untreated' or treated rats fed sucrose, glucose, fructose or 
an equimolar mixture of glucose and fructose, for 14 days did not
TABLE 6*2
EFFECT OF DIETS CONTAINING 60$ CARBOHYDRATE 
ON BODY WEIGHT (g)
Results for 'untreated1 animals are the means 
for 10 animals and those for the 'treated' ones 
the mean for 5 animals, with standard error
STARCH SUCROSE GLUCOSE FRUCTOSE GLUCOSE
and
FRUCTOSE
UNTREATED 121 128 131 120 123
(Diet:24-38d) + 4 ±. 4 +_ 4 + 5 + 5
UNTREATED 137 127 133 120 128
(Diet :24-37d) + 4 + 3 + 7 + 4 t  5
TREATED 141 130 144 126 139
(Diet:37-38d) + 4 + 4 + 9 + 5 + 4
Table 6*3 EFFECT OF DIETS CONTAINING 60$ CARBOHYDRATE ,
ON LIVER WEIGHT
Each result is the mean for the number of animals 
shown in Table 6*2 with standard error £
STARCH SUCROSE GLUCOSE FRUCTOSE GLUCOSE
and
FRUCTOSE
Absolute (g)
UNTREATED 5.0 **6.6 **6.2 *5.8 **6.4
+0.3 +0.3 +0.3 +0 *4 +0.3
■ ■ •— .
TREATED 6.4 **7.6 **7.9 **7.8 **8.2
+0.4
Relative to body weight
+0.3
w
+0.4 +0.5 +0.5
UNTREATED ' 4.1 **5.1 **4.7 **4.8 **5.2
+0.1 +0.2 +0.1 +0.3 +0.2
TREATED 4.5 **5.8 **5.5 **6.1 **5.8
+0.1 +0.1 +0.1 +0.2 +0.2
Statistically significant difference between 
the animals fed starch and those fed other 
other carbohydrates: * = P < 0.05; ** - P < 0.01*
differ significantly in body weight from those fed starch (TableSE*2^« 
The liver weights (Table 6.3), however, were significantly higher 
in animals fed sucrose, glucose and an equimolar mixture of glucose 
and fructose than in those fed starch, but unlike the body weights, 
the liver weights were significantly increased in all groups after 
phenobarbital treatment, and the difference between the animals £ ed 
starch and those fed other carbohydrates remained similar. The 
weight of the liver relative to that of the body was significantly
higher in all groups, either treated or untreated, compared to
the group fed starch.
The animals fed sucrose and the monosaccharides showed
significantly lower specific activities of the biphenyl 
4-hydroxylase (per g. liver weight) compared to that of starch, but 
the depression of the activity was greater in rats fed sucrose and 
the equimolar mixture of glucose and fructose (Table 6.4). Pheno­
barbital induced the enzyme in all groups, but the activity in the 
starch fed.rats remained higher than that of all the other groups.
Table 6.4
EFFECT OF DIETS CONTAINING 60% CARBOHYDRATES
ON THE ACTIVITY OF BIPHENYL 4-HYDROXYLASE
Each result is the mean f-or the number of animals 
shown in Table 6.2 with standard error +
STARCH SUCROSE GLUCOSE FRUCTOSE GLUCOSE and
FRUCTOSE
Specific activity (pmole/g.liver wt/hr.)
UNTRE1TED 4.1 ■*** 2.6 ** 3.5 ** 3.4 *** 2.9
*+0.1 +0.1 +0.1 +0.3 +0.1
TREATED 6.4 *** 4.6 ** 5.4 ** 5.2 ** 5.5
+0.2 +0.2 +0.1 +0.1 +0.2
Total activity (pmole/liver/hr.)
UNTREATED 20.4 **16.9 21.5 19.2 ■ 18.6
+ 1.2 + 1.0 + 1.1 +1.4 + 1.0
TREATED 40.4 **35.4 42.7 40.2 44.0
+ 1.5 + 1.7 +2.6 +2.5 +4.0
Statistically signilicant difference between the animals fed starch 
and those fed other carbohydrates: ** = P < 0.01; *** = p <’ 0.001.
However, the difference between animals fed the equimolar mixture 
of glucose and fructose and those fed the monosaccharides alone had 
disappeared# The sucrose fed rats, whether untreated or treated 
with phenobarbital showed a significantly lower total activity per 
liver than the other groups#
The activity of biphenyl 2-hydroxylase (Table 6.5) was also
found to be higher in animals fed starch than others. In fact,
& -
the activity of this enzyme was hardly trac|able in animals fed 
the dietary sucrose.
Table 6.5 EFFECT OF DIETS CONTAINING i60$ CARBOHYDRATES
ON THE ACTIVITY OF BIPHENYL 2-HYDROXYLASE
Each result is the mean for 
animals shown in Table 6.2.
the number of
ACTIVITY STARCH SUCROSE GLUCOSE FRUCTOSE
Concentrati on 
(ji.mol/g.liv./hr.
0.19 < 0.01 0.06 0.12
Absolute amount 
(p,.mol/liver/hr.
1.0 < 0.1 0.4 0.7
Unlike biphenyl 2- and 4-hydroxylases,the specific activity of p-nitro- 
benzoate reductase (Table 6.6) was increased by fructose or glucose 
alone, but not when given as an equimolar mixture, or combined as 
sucrose. The differences between the groups disappeared, however,
when phenobarbital was given. The total activity per liver remained 
significantly lower in the starch fed rats, either treated or 
untreated, than in all other groups, although the total activity 
in rats fed sucrose appeared to be lower than either glucose or 
fructose fed animals.
Table 6.6 EFFECT OF DIETS CONTAINING 60$ CARBOHYDRATES
ON THE ACTIVITY OF p-NITROBENZOATE REDUCTASE
Each value is the mean for the number of animals 
shown in Table 6.2 with standard error +_
STARCH SUCROSE GLUCOSE FRUCTOSE GLUCOSE i
FRUCTOSE
Specific activity (pmol/g.liver weight/hr.)
UNTREATED 1.0 1.2 **1.8 **1.7 1.3
I0'1 + 0.1 +0.1 +0.1 +0.1
TREATED 1.4 1.4 1.8 1.8 !*6
+0.1 +0.2 +0.1 +0.1 + o •
Total activity (pmol/liver/hr •)
UNTREATED 5.1 •■•***7.8 ***11.4 ***9.9 ***8.2
+0.3 +0.7 +0.6 +0.9 +0.8
TREATED r 8.7 **10.5 ***14.3 ***14.2 ***13.2
+0.5 +0.5 +0.9 +_ 1.3 + 1.2
Statistically significant difference between the 
animals fed starch and those fed other carbohydrates : 
** = P < 0.01; ***• = P < 0.001.
Sucrose and the monosaccharides tended to result in a decrease 
in the level of cytochrome P-450 per g. liver weight, and this pattern . 
was enhanced by phenobarbital (Table 6.7). In the untreated 
animals, there was no difference between the groups with respect 
to the total amount per liver, but treatment with phenobarbital 
resulted in significantly higher amounts in the rats fed starch.
TABLE 6.7
EFFECT OF DIETS CONTAINING 60$ CARBOHYDRATES
ON THE LEVEL OF CYTOCHROME P-450
Each value is the me an fa.’the number of animals 
shown in Table 6.2 with standard error +_
STARCH SUCROSE GLUCOSE FRUCTOSE GLUCOSE and
FRUCTOSE
Concentration (n.mol/g.liver weight)
UNTREATED 19.8 **15.4 **16.2 *18.0 *17.6
+0.5 ' +0.5 ’ +0.9 +1.0 +0.4
TREATED 40.0 ***28.8 ***24.8 ***30.4 ***25.0
+ 1.0 +1.1 +1.5 • +2.3 ±0.6
Total amount (n.mol/liver)
UNTREATED 99 101 100 103 113
+6 +7 +8 +7 + 6
TREATED 254 *219 *197 232 *189
+14 + 7  +20 +12 +19
Statistically significant difference between 
the animals fed starch and those fed other 
carbohydrates:
* = P < 0.05; ** = P.< O.Oi; *** = .P < 0.001.
The effects of various carbohydrate diets on the hepatic 
concentration of biphenyl 4-hydroxylase, p-nitrobenzoate reductase 
and cytochrome P-450 relative to starch have been summarized in 
Table 6.8. The specific activity of oxidative enzyme, biphenyl 
4-hydroxylase was lower in all groups fed sucrose and monosaccharides,
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and on the other hand, the activity of reductive enzyme, p-nitro- 
benzoate reductase was higher in those animal^. Cytochrome P-450 . ; 
tended to be similar to biphenyl 4-hydroxylase in that sucrose and 
the monosaccharides resulted in a decreased hepatic concentration*
In the case of biphenyl 4—hydroxylase, feeding sucrose or an 
equimolar mixture of glucose and fructose produced a greater 
depression of activity in the untreated animals than did the other 
carbohydrates.
(ii) Composition of the liver of animals given 60$ sucrose
The concentration of protein and INA in the liver was depressed by diet- 
aiy sucrose (Table 6. 9)\The concentration of phospholipid-P was, however, 
the same in animals fed sucrose as it was in those fed starch. The 
nature of the dietary carbohydrate made no difference to the amounts 
of protein and IMA per liver, but because the liver weight was
increased by feeding sucorse, the absolute amount of phospholipid-P
was significantly increased by sucrose.
Table 6.9
EFFECT OF DIETARY 60$ SUCROSE ON THE
LIVER COMPOSITIONS
Each value is the mean for the number of
animals shown in Table 6.2 with standard
error +
DIET PROTEIN DNA 
per g. liver
PHOSPHOLIPID-P
weight
STARCH 242 + 9 4.8 +_ 0.3 1.3 + 0.03
SUCROSE *214 + 14 **3.6 +0.3 1.3 + 0.06
mg.. per liver
STARCH 1210 + 78 24.0 + 1.5 6.5 +0.2
SUCROSE 1379 + 92 23.7 + 0.8 **7.6 +0.3
Statistically significant difference between animals fed starch 
and those fed sucrose: * = P < 0.05; ** =- P < 0.01.
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(b) Effect of a diet containing 10$ sucrose on the body weight, 
liver weight, biphenyl 4-hydroxylase and cytochrome P-450 
in the liver of young and adult rats.
In rats given a diet containing only 10$ sucrose with 50$ starch 
for 25 days, the body weight and liver weight was the same as that 
of rats fed a diet containing 60$ starch, but the activity of 
aromatic hydroxylase (Table 6ol0) was depressed. The level of 
cytochrome P-450, however, was not significantly lower. In adult 
animals, a 10$ sucrose diet had no significant effect on the activity 
of biphenyl 4-hydroxylase.
(c) Effect of different disaccharides on the body weight, liver, weight 
and activity of biphenyl 4-hydroxylase.
Since the activity of biphenyl 4-hydroxylase was depressed by 
feeding sucrose, it was of interest to study the effect of other 
disaccharides on this enzyme. A diet containing 60$ lactose resulted 
in a lower body weight and liver weight (Table 6.11). The specific 
activity of hepatic biphenyl 4-hydroxylase (per g liver weight) was, 
however, increased by lactose, but due to smaller liver weight the 
total amount was the same as in the starch-fed animals. Animals fed 
a diet containing maltose, were of similar body weight and had 
similar liver weight to those fed starch. The activity of biphenyl 
4-hydroxylase in the liver was also similar.
DISCUSSION
The present studies have shown that compared, with the effect of 
starch, a diet containing 60$ sucrose or its constituent monosaccharides, 
increased the weight of the liver in weanling rats; this is in agreement 
with the observation of others (Macdonald, 1964; Allen and Leahy, 1966)#
The enzymes biphenyl 2- and 4—hydroxylase involved in the 
hydroxylation of drugs and foreign compounds respond to dietary 
carbohydrate differently from p-nitrobenzoate reductase, which is 
involved in the. reduction of foreign compounds. Thus, whilst the 
specific activity of the former enzymes was reduced by giving sucrose, 
glucose and fructose, the activity of the latter enzyme was increased. 
Cytochrome P-450 paralleled the loss in activity of the biphenyl 
hydroxylase which would be expected as a correlation between cytochrome 
P-450 and oxidative enzymes has been established (Orrenius and Emster, 
1964; Kato and Gillette, 1964)* However, other workers (Gillette et al, 
1968) have obtained a similar correlation between cytochrome P-450 and 
p-nitrobenzoate reductase, and this is clearly not supported by the 
present findings.
The activity of biphenyl 4-hydroxylase was reduced not only by 
feeding 60$ sucrose to weanling animals but also by feeding 10$, and this 
was true whether the activity is expressed per gram liver weight or per 
total liver weight. The depression caused by 10$ sucrose was not 
observed in adult animals. It seems clear therefore that the rapidly 
growing animals were more susceptible to the dietary intake of sucrose. 
The mechanism by which dietary sucrose depresses the activity of biphenyl 
hydroxylases and the level of cytochrome P—450 in weanling rats remained 
to be elucidated.
As substrate and co-factors used in the enzymic assay were added 
in concentrations which prevented their being rate-limiting, the 
observed alterations in enzymic activity are unlikely to be due to 
changes in the rate of production of co-factors, such as, NADPHp or
An alternative mechanism by which metabolism might be altered 
would be a change in the turnover rate of the enzyme protein. As 
turnover implies both synthesis and breakdown, a decrease in the 
concentration of biphenyl hydroxylase^might occur simply by increasing 
the catabolic reactions by which the enzyme protein is degraded.
As a significant fall in serum albumin has also been reported in 
humans on a high sucrose intake (Brice et al, 1969), a study in sucrose 
fed rats of the turnover rates of protein synthesis, especially of those 
enzyme proteins concerned with drug-metabolism, is merited.
A third mechanism could, concern the absorption of sucrose. 
Disaccharides are normally hydrolysed into monosaccharides by their 
specific disaccharidases present in the intestinal mucosa (Crane, I960). 
However, the details of the kinetics of this enzymic process of hydrolysis 
and absorption, and the location of the relevant enzymes are still under 
investigation (Newey, 1967). What does emerge is that the absorption 
of total monosaccharides following a diet of sucrose is not the same as 
that obtained from its equivalent of glucose plus fructose (Cook, 1970).
As intestinal sucrase in the rat is an inducible enzyme, continuous 
feeding of sucrose may result in different patterns of induction.
Rubino, Zimbalatti and Auricchio (1964) reported, that in rat the activity 
of sucrase appears 15 or 16 days after birth, and around the 20th day, 
the activity reached adult values. These workers also showed that
sucrose feeding (220 mg./day for 2 days) to 12-day old rats does not 
induce sucrase activity. It has further been reported that it takes 
about 5 days to induce sucrase activity by substrate in the human intestine 
(Rosensweig and Herman, 1969). However, the time required for induction 
of the disaccharidase activity in the weanling rat is not known and it 
could be that these animals require different periods for induction than 
either human or adult rats. Thus differences of activity of intestinal 
disaccharidase and difference in the extents of absorption of non­
hydrolysed sucrose may well account for the differences observed between 
the weanling and adult rats in their levels of hepatic drug-metabolizing 
enzyme activity. Due to this inconclusive evidence regarding the 
absorption of sucrose and for its constituent monosaccharides the results 
presented in the current investigation are not readily explicable.
However, a number of factors such as the previous dietary regimen, 
induction of intestinal sucrase, and the toxic effects of sucrose 
absorbed unchanged, may play a role in producing the observed effects.
Unlike sucrose, feeding other disaccharides, lactose or maltose, 
did not cause any depression of the activity of biphenyl 4-hydroxylase. 
Substitution of starch by lactose, however, restricted the gain of body 
weight and of liver size. If body weight is considered as an index 
of nutrition, animals fed lactose appeared to be undernourished, and 
this could be due to the reduction of food intake or due to the 
impairment of the digestion of lactose, which in turn is dependent 
on the activity of intestinal lactose. Rubino and his associates (1964) 
have shown that unlike the intestinal sucrase activity, the activity of 
intestinal lactase is very high at birth, and later it diminishes 
gradually and reaches the low levels of adult rats. These workers 
did not investigate whether the lactase is maintained at -previous
levels of activity if lactose is added to the diet of the 
weanling animals. However, it has been reported elsewhere that lactase 
activity cannot be induced in normal as well as lactase deficient humans 
with lactose feeding (Rosensweig, 1971). If the lactase is not 
inducible after weaning by feeding lactose,in the current investigation, 
the administration of 58$ of the total dietary calories as lactose to 
weanling rats would mean a severe depletion of dietary carbohydrate 
and total nutrition.
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CHAPTER VII
GENERAL DISCUSSION, IMPLICATIONS AND CONCLUSIONS
GENERAL DISCUSSION, IMPLICATIONS AND CONCLUSIONS
1. GENERAL DISCUSSION
The activity of the hepatic drug-metabolizing enzymes is dependent 
on a number of factors such as age, species, genetic constitution, - 
body temperature, sex, and the nutritional status of the animal (see 
Chapter 1). In the investigations which have been described, two 
of these factors are selected for further investigation, namely, age 
and nutritional status. The present study has revealed information 
which may contribute to the knowledge pertaining to the hazards of 
prescribing drugs to undernourished children. Normally, such 
prescription is based on information derived from normal adults, but 
this work has shown that malnourished experimental animals have 
impaired liver function, a different capacity to metabolise drugs and 
hence are more vulnerable to the pharmacological activities of these 
drugs and to their toxic side-effects.
(i) Developmental pattern of drug metabolizing enzymes
The study in rats of the pattern of development of cytochrome P-450, 
which is involved in the electron transport system for the hepatic 
microsomal hydroxylation of drugs, and similar studies of the drug- 
metabolizing enzyme activities such as bijDhenyl hydroxylation, 
p-nitrobenzoate reduction, and 4-methylumbelliferone conjugation with 
glucuronide, has yielded significant new information concerning the 
metabolism of drugs. The activities of these enzymes and cytochrome 
P-450 at 6-70 days postnatum fall*into three distinct phases. The 
first phase, as measured on the 6th day postnatum, showed a period of 
very little activity. This was followed by a rapid and. nearly
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linear increase in activity which lasted until 3 to 5 weeks after 
birth# The third phase, from about the 5th to 10th week, showed 
a decrease in activity until it reached the mature level at about 50-70 
days of age#
The rate of development of the drug-metabolizing enzymes studied 
in the current investigation was generally similar to that of other 
enzymes involved in drug-metabolism, which has been described for the 
rabbit, guinea pig, rat and swine. Fouts and Adamson (1959) found 
that the activity of oxidative enzymes developed rapidly in rabbit 
liver after birth, reaching 50 to 100^ of adult activity by the fourth 
week of age# A similar pattern was observed in the guinea pig by 
Jondorf et_ al_ (1959), Kato et al (1964) found that the rate of oxidative 
metabolism of several drugs by the liver of female rats increased 
rapidly from birth to 30 days of age, and then began to decrease with 
increasing age. Short and Davis (1970) showed that in the liver 
of swine the greatest rate of increase in activity of certain drug- 
metabolizing enzymes occurred during the first three to four weeks 
postpartum, It seems that the developmental pattern of drug-metabolizing 
enzymes.is common among mammalian species, and furthermore that the 
phase of most rapid development occurs between birth and the third 
to fifth week postpartum, regardless of such factors as the size of 
species, the length of its gestation period, the maturation time and 
normal life span of the animal. There is also a considerable body 
of evidence to suggest that the developmental pattern of the microsomal 
enzymes derived from the various animal studies, may be applicable to
140
man# For example, it has been shown that chloramphenicol toxicity 
is more severe in newborn infants tian in older children "(Weiss," 
Glazko and Weston, I960). A further example which signifies the 
purpose of the present studies in relation to man is derived from 
the recent study of O’Malley, Crooks, Duke and Stevenson (1971) in 
which it is indicated that the mean plasma half-life values of 
antipyrine and phenylbutazone were greater by 45$ and 29$ 
respectively in male geriatric patients than in young adults, 
indicating a decreased rate of drug-metabolism in the aged. The 
importance of the age of the animal in the study of drug-metabolism 
and drug actions although derived mainly from studies on the rat 
and other laboratory animals may, as has been illustrated, be 
extrapolated to humans.
Although most of the drug-metabolizing enzymes increased until 
they reach the adult level, exceptions do exist. One such exception 
is the biphenyl 2-hydroxylase, the activity of which rises to a 
maximum at 21 days and completely disappears after 52 days of age.
The explanation of this disappearance is, however, unknown, although 
it is possible that this enzymic activity is a model for the 
oxygenation of some endogenous component concerned in the development 
of the animal and is not normally concerned with the hydroxylation 
of drugs and other foreign compounds.
(ii) Effect of phenobarbital on the microsomal enzymes of rats
of different age#
The hepatic microsomal enzyme systems of both the immature and 
mature rats can be stimulated by pretreating the animals with 
phenobarbital. The significance of phenobarbital-induced stimulation
of the clrug-metabolizing enzyme activity in all periods of life, 
and in particular the early postnatal period, has probably not 
been fully appreciated. Many drugs have the unique property 
of increasing not only their own metabolism, but also the 
metabolism of other drugs and xenobiotics (Conney, 1967).
Thus phenobarbital administration to the rat increases the 
metabolism of hexobarbital and zoxazolamine as well as that of 
phenobarbital. That the increased enzyme activity is due, 
at least in part, to an increased synthesis of enzyme protein 
is based upon the following observations:
1. There is a simultaneous increase in the concentration of 
hepatic protein and of the smooth membranes of the endoplasmic 
reticulum, the main site of drug-metabolizing enzymes (see 
Chapter i).
2. Ethionine, actinomycin D and thioacetamide, inhibitors of 
messenger ENA and protein synthesis, substantially reduce the 
increase in enzyme activity.
3. The increased enzyme activity cannot be demonstrated by 
treatment of the isolated enzyme fraction with the inducer 
in vitro.
Enzyme induction in the immature animals also serves to determine 
whether the low enzyme activity observed in untreated animals is due 
to the inability of the enzyme-synthesizing system to be stimulated 
or to a lack of stimulus. Administration of phenobarbital to 12—day
old rats increased the activity of biphenyl 4-hydroxylase by a factor 
of 2*5, while 52-day old rats responded by a factor of only 1*5.
It is not, however, known whether the suckling rat is intrinsically 
more responsive to a given dose of phenobarbital than the older
ones, or whether the greater response of the suckling rat to
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enzyme induction is caused by the relatively slower metabolism of 
the enzyme inducer to inactive metabolites# In any case, studies 
of enzyme induction in the growing period may help elucidate the 
mechanism of induction by pharmacologic agents, provide an insight 
into the entire process of mammalian development, and yield 
information about drug toxicology, chronic drug therapy and 
mechanism of tolerance#
(iii) Relationships between the protein-calorie malnutrition and 
the hepatic microsomal enzyme systems
o
There is little or no reference in the literature pertaining 
to the effects of protein-calorie malnutrition on drug tolerance, 
nor has it been stated whether desired therapeutic effects can 
be achieved with lower dosage of a particular drug in a protein 
deficient or undernourished subject. It is, however, evident 
from the current investigation that undernutrition during the first 
three vreeks of postnatal life results in no change in the hepatic 
concentration of drug-metabolizing enzymes as compared to the 
controls of the same age. In male weanling rats fed a protein 
deficient diet with or without additional calories, the hepatic 
concentration of the enzymes is, in general increased. The 
hepatic concentration of glucuronyl transferase is, however, 
depressed in the absence of additional calories and cytochrome
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P-450 is depressed in the presence of additional calories. 
Nevertheless the absolute amounts of the enzymes per whole 
liver are generally depressed throughout the investigation 
period by both dietary regimes. An exception is seen in the 
animals fed the protein deficient diet with additional calories, 
where the rise in the hepatic concentration of biphenyl 
4-hydroxylase is sufficient to compensate for the lower liver 
weight so that the total amount per liver is the same as in the 
controls. It therefore follows that the interpretation of 
results depends upon the choice of the base of reference.
The changes in activity per unit weight are not the same as 
changes in the total activity of the whole liver. The liver 
weight, however, is severely depressed by the protein deficient 
diet with or "without additional calories, and therefore it is 
to be expected that the enzyme levels in terms of total amounts 
would also be depressed by these diets. High concentration 
of the enzymes indicates that the specific enzyme protein is 
being maintained at or above the normal level in the protein 
deficient animals, and this makes the specific activity of the 
enzyme more significant than the absolute amount as a reference 
base.
(iv) The adaptive response of biphenyl 4-hydroxylase to the 
protein deficient diet-
The adaptive response of biphenyl 4~hydroxylase to the protein 
deficient diet is further emphasized by demonstration of the effect 
of a protein-free diet on the activity of the enzyme. A protein-
free diet fed for 28 days results in a reduction of the body 
weight of 30$, so that the' weights of body and liver are 
only 18$ and 13$ respectively of that in the controls of the 
same age. The microsomal protein concentration is also 
significantly lower in the rats given the protein-free diet 
than that in the control ones. In spite of these deleterious 
affects of the diet, the specific activity of biphenyl 
4—hydroxylase in the animals fed the protein-free diet 
is significantly higher than in the controls.
The adaptive response of biphenyl 4-hydroxylase to the 
protein deficient or protein-free diet observed in the in vitro 
studies has been further supported by the findings that the 
capacity of the body to metabolize biphenyl and excrete it as 
hydroxylbiphenyl in the urine is similar in control animals 
and those fed a protein deficient diet for 28 days. Thus 
the in vivo metabolism of biphenyl appears to parallel the 
activity of biphenyl 4-hydroxylase measured in vitro.
(v) The hypothetical mechanisms for the adaptive response of
biphenyl 4-hydroxylase to the protein deficient diet
One might perhaps think that a determination of the kinetic 
constant of the enzyme, biphenyl 4-hydroxylase, in the normal 
and in the protein deficient rats, would shed some light on the 
cause of the stimulatory effect of the protein deficient diet. 
However, kinetic studies of this enzyme shows no change in the 
apparent Michaelis constant (Km) between the control:and the
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protein deficient rats, and. thus the possibility of a conformational 
change of the enzyme site which might have resulted in the increase 
of activity is considered to be unlikely.
Water low (1968) has concluded that adaptation of many 
enzymes involved in intermediary metabolism to a low protein 
diet is accompanied by -
1, No significant decrease in the total nitrogen turnover,
2, A reduction in the synthesis of protein in muscle whilst that 
in the liver is well maintained or increased, and
3, A more efficient re-utilization of amino acids for synthesis 
after their liberation by catabolism.
Since this hypothesis for adaptation involves inverse effects in 
liver and muscle, it has been postulated that cortisol may be 
responsible for the initiation of the response, since cortisol 
promotes protein synthesis in the liver, while it causes a 
negative nitrogen balance in.the body as a whole. It seems 
possible, therefore, that alterations in the pattern bf protein 
turnover which occur in adaptation may be explained by an increase 
in the level of cortisol.
In the current investigation, the protein deficient rats 
after two or four weeks on the diet showed an increase in hepatic 
concentrations of biphenyl 4-hydroxylase of 70-100$ and an increase 
in plasma corticosteroids of 150-200$, Thus a correlation between 
the increase of biphenyl 4-hydroxylase activity and plasma 
corticosteroid level in protein deficient animals becomes evident.
These results are also in agreement with the work of Alleyne and 
Young (1966) who showed that in malnourished children, plasma 
cortisol levels are consistantly about twice normal* Further, 
Alleyne and Young (1967) have also shown that the increased 
level of cortisol in malnourished infants is not due to its 
increased synthesis but to the reduction of its degradation.
This could be due to an impaired hepatic degradation of the 
cortisol resulting from the effects of malnutrition.
It could be that the tissues are thus exposed to a high 
concentration of corticosteroids which'might help to produce 
the enzyme changes described, above.
The possibility of the adaptive response in rats being 
mediated by corticosterone is supported by the observed increase 
in the concentration of biphenyl 4-hydroxylase as a result of 
corticosterone administration in well-fed animals. In addition, 
it has been suggested by Weber, Srivistava and Singhal (1964) 
that in rats corticosteroid-mediated enzyme induction involves 
changes in protein synthesis.
(vi) Relationships between dietary carbohydrates and microsomal 
enzyme system
All the diets used for weanling rats in the investigations 
mentioned so far contain starch as the carbohydrate. It is now 
being increasingly realised that the nature of the dietary 
carbohydrate is as important as its quantity. The studies on 
the effect of various dietary carbohydrates on the drug-metabolizing 
enzymes, reveal that the substitution of sucrose for starch depresses
the activity of biphenyl 2- and 4-hydroxylases and the concentration 
of cytochrome P—450 in male weanling rats. The absolute amount of 
these enzymes in whole liver is not, however, similarly depressed 
by the constituents of sucrose, namely glucose and fructose, 
either when given alone or in an equimolar mixture. From these 
results, one-might perhaps assume that either hydrolysis of sucrose
in the intestine, or its absorption as unhydrolysed sucrose, could be 
the limiting factor for the observed depression of the oxidative 
system by dietary sucrose. It is true that intestinal sucrase 
can be modified by diet (Blair, Yakimets and Tuba, 1963), but 
the relationship of adaptation to physiological function is not 
well defined. Thus the depressed levels of the biphenyl hydroxylases 
and cytochrome P-450 can be implicated as functionally significant 
in disaccharide malabsorption only if the sucrase level is rate 
limiting and variations in disaccharidase levels are reflected by 
changes in the disaccharide absorption. This is, however, only 
speculation, and certainly needs further investigation.
(vii) Relationsips between the level of cytochrome P-450 and, the 
activity of biphenyl hydroxylases
In accordance with the prevailing consensus of opinion that 
the concentration of cytochrome P-450 parallels the rate of 
hydroxylation of xenobiotics, the present study in sucrose-fed 
rats demonstrates that a decrease in the activity of biphenyl 
4-hydroxylase is accompanied by a decrease in the level of 
cytochrome P-450. Further, the induction of 4—hydroxylase by 
phenobarbital treatment parallels the increase in the cytochrome 
P-450 concentration. This however is not always the case, as it
has been demonstrated that in protein deficient animals the 
concentration of cytochrome P-450 decreases while the activity of 
biphenyl 4— hydroxylase increases* Although the present findings 
cannot be readily interpreted, it is clearly demonstrated that 
the hydroxylation of biphenyl is not solely dependent'on the 
cytochrome P-450 but that other factors may also be involved.
Recent studies (Davies, 1969) have established that a rate 
limiting step in the overall oxidation of a drug by liver 
microsomal enzymes is the reduction of the cytochrome P-450- 
drug complex# The lack of correlation between cytochrome P-450 
and the activity of biphenyl 4-hydroxylase in the protein deficient 
animals lends support to the view that some other component is 
involved in the transfer of electrons from NADPH cytochrome c 
reductase to cytochrome P-450. If these differences are due to 
variation in a rate limiting component such as cytochrome P-450 
reductase, then it might be that animals could be classified as 
either fast or slow ’hydroxylatorsand that this classification 
would hold for different dietary status.
2. IMPLICATIONS
In the current investigation, it is evident that food 
deprivation delays the development of the absolute amount of the 
activity of hepatic microsomal drug-metabolizing enzymes in the 
growing rat. It is possible that this occurs in man. If so, 
this might have some implications on the development of drug- 
metabolizing enzymes in cases of chronic undernutrition in early
life of humans, and therefore, caution might well be required in 
the dosage and prescription .of drugs for malnourished individuals* 
Further, it appears that in protein-calorie malnourished rats, 
the hepatic concentration of certain drug-metabolizing enzymes 
shows an adaptive response, the substrate required for this 
response being derived from the diet. This in fact imposes 
an extra requirement on the malnourished animals in view of the 
fact that the nutrients necessary for the said response must be 
derived endogenously. In view of the world food shortage and 
the present prevalence of malnutrition in developing countries 
it seems important to assess the effects of nutritional status 
on drug-metabolism in man. Also, in an affluent society we 
cannot afford to be unaware of this problem since the very 
patients to whom pharmacological agents are given in full 
dosage and for prolonged periods are so often those whose
nutritional status may have been impaired by the primary disease
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for which the drugs are recommended. While emphasis lias been 
rightly placed on the pharmacological and toxicological properties 
of drugs per se, this should not lead to a neglect either of the 
effect of nutritional status on drug safety or of the chances 
of iatrogenic malnutrition.
Another implication of the present work is that phenobarbital 
treatment has been found to induce to a greater extent the activity 
of drug-metabolizing enzymes in undernourished rats than in well 
nourished ones. There is a possibility that this may also be 
so in the human, in which case the enzyme inducer could be used to 
stimulate the metabolism of drugs when this is impaired by dietary 
restriction. Further, the ability of phenobarbital to enhance
liver growth as indicated in the results of the present study, and 
in liver regeneration (preis-, Schaude and Siess, 1966), raises 
the question of whether such drugs would be useful in patients 
with poor liver function, such as hepatic cirrhosis, arising 
from protein malnutrition. However, the physiological 
implications of enhanced liver growth in animals treated with 
phenobarbital has not yet been determined, and it has not been 
clarified whether these affects are harmful or beneficial. •«-
This field therefore is open to further investigation.
It is also evident from the current investigation that 
hydroxylases and cytochrome P-450 are depressed in the growing 
rat by dietary sucrose. It is possible that this may also 
occur in infants or in young children, in which case the 
administration of drugs to children in a sucrose-based syrup 
is contra-indicated. Furthermore, in view of the fact that in 
the affluent society, sugar intake accounts for about 20$ of 
the total, calories (Yudkin, 1965), it seems important to assess 
the effects of sugar intake on drug-metabolism in man.
3. CONCLUSIONS
The study of drug-metabolism in relation to the nutritional 
status in growing rats may be viewed as an extension of our 
constant search for factors that modify drug action. In this 
instance, age is the determinant of activity. The importance 
of understanding the complex mechanisms involved in the metabolism
of drugs in the grooving animals has been highlighted, albeit 
incompletely. The incompleteness represents, in part, our 
inability at present to explore all the factors involved, 
due to lack of precise quantitative techniques and to an 
incomplete understanding of the mechanisms of the changes in 
the metabolism of an animal from conception to adulthood.
It is hoped that the development of these disciplines will 
provide an insight into the metabolism of drugs, and will 
shed light on to the relationship between drug-metabolism and 
nutritional status, not based on dogmatic posologic principles, 
but rather on precise developmental requirements. The 
current investigation, however, should be extended to other 
drug-metabolizing enzymes involved in the various metabolic 
deactivating reactions (Table 1).
Cytochrome P-450 involved either directly or indirectly, 
as a terminal oxidase for hydroxylation of drugs, is a haemo- 
protein (Omura and Sato, 1964). It seems likely, therefore, 
that the level of this haemoprotein may be affected by an 
iron-deficient diet. No work, however, has been so far 
reported on the relationships between iron intake and drug- 
metabolizing enzymes, and thus this field of study still remains 
open for investigation.
The present study indicates that the nutritional status does 
alter the activities of various drug-metabolizing enzymes. On 
the other hand, there is evidence that drugs may also influence the 
nutritional status (Fig.7^1). Drugs may have an appetite-depressing
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(Fig# 7,1. Effect of drugs on factors affecting nutritional status
(Christakis and Miridjanian, 1968)
effect, as do amphetamines. They may irritate the gastric 
mucosa and cause nausea and vomiting. They may influence the 
bacterial flora in the intestine or directly affect the absorption 
of nutrients. With new drugs becoming available at an increasing 
rate, knowledge must be obtained concerning their immediate and 
long-term metabolic effects. The complex relationships between 
drugs and nutritional status is a relatively unexplored field 
which needs further investigation, and this could be linked with 
the current studies.
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Effect of Development on the Activity of 
Microsomal Drug-Metabolizing Enzymes in Rat Liver
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1. The activity of rat liver microsomal drug-metabolizing enzymes was deter­
mined at various ages between 6 and 100 days post natum. The enzymes studied 
were: aromatic hydroxylases by using as substrate biphenyl, which is metabolized 
by oxidation to 2- and 4-hydroxybiphenyl; nitroreductase by usingp -nitrobenzoate 
as substrate, which is metabolized by reduction to p-aminobenzoate; glucuronyl 
synthetase by using 4-methylumbelliferone as the substrate, which is conjugated 
to give 4-methylumbelliferone glucuronide, and cytochrome P-450, which is 
regarded as the major terminal mixed-function oxidase in hepatic microsomal 
hydroxylations. 2. The activity of biphenyl 2-hydroxylase reached a peak at 21 
days, biphenyl 4-hydroxylase and 4-methyl glucuronyl transferase at 24 days, 
cytochrome P-450 at 31 days, and p -nitrobenzoate reductase at 38 days of age. 
After the peak activity had been reached, the activity of each enzyme decreased 
with age, and in the case of biphenyl 2-hydroxylase the activity fell to a negligible 
value at 52 days of age. 3. Neither the addition of Triton X-100 to the incubation 
medium nor the treatment of the animals with phenobarbital resulted in any 
increase in the activity of biphenyl 2-hydroxylase at 52 days of age. 4. The activity 
of biphenyl 2-hydroxylase was threefold higher in rats fed on a synthetic diet than 
in rats fed on a commercial stock diet. 5. These findings are discussed.
The development of the components of rat liver 
has been studied extensively, but less information 
is available on the development of the activity of 
the hepatic drug-metabolizing enzymes. The liver 
microsomal fraction of m a n y  newborn animals, 
including mice and guinea pigs, is deficient in 
certain drug-metabolizing enzymes (Jondorf, 
Maickel &  Brodie, 1959). The activities of several 
hepatic enzyme systems that metabolize drugs by 
hydroxylation or by reduction have been shown to 
be absent in newborn rabbits, with some activity 
appearing at 14 days after birth, and full adult 
activity at 28 days (Fouts &  Adamson, 1959). 
Similarly, newborn rats have been shown to have 
little capacity to metabolize a number of drugs, 
but both the total activities and the specific 
activities of a number of these enzymes progres­
sively increase with age up to 30 days, then after­
wards decrease gradually (Kato, Vassanelli, Frontino 
&  Chiesara, 1964). A  study in the rat of the develop­
ment of hepatic aniline hydroxylase and ethyl- 
morphine demethylase showed that both the total 
activities and the K m values of these enzymes 
increased during the first few weeks after birth, but 
there was no correlation between the two enzyme 
activities nor between either of these and the
hepatic cytochrome P-450 content (Gram, Guarino, 
Schroeder &  Gillette, 1969). Other workers have 
studied the development of microsomal glucuronyl - 
transferase in the liver of newborn rabbits (Flint, 
Lathe, Ricketts &  Silman, 1964), the conjugation 
with G S H  of sulphobromophthalein in mouse liver 
(Krasner, 1968),thehydroxylationof 7,12-dimethyl- 
benz[a]anthracene in rat liver (Sims &  Grover, 
1967), and a number of oxidative, reductive, 
hydrolytic and synthetic drug-metabolizing 
enzymes in the liver of the pig (Short &  Davis, 
1970). All of these studies have shown a charac­
teristic development of these enzymes during the 
first 4-6 weeks after birth.
The present work was undertaken to investigate 
further the correlation of the development of a 
number of hepatic drug-metabolizing enzyme 
activities with the concentration of hepatic cyto­
chrome P-450 in the rat. The enzymic activities 
include aromatic hydroxylation, measured by the 
2- and 4-hydroxylation of biphenyl, nitro-reduction, 
measured by the reduction of p -nitrobenzoate, and 
glucuronide synthesis, with the substrate 4-methyl­
umbelliferone. In the present investigation the 
activity of the liver microsomal enzymes has been 
measured in  vitro from 6 days of age to maturity,
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in animals of known age reared under controlled 
conditions. The effect of feeding a purified diet 
during gestation, lactation and the post-weaning 
period, on the activity of the hepatic microsomal 
enzymes has also been studied. Further, the 
development and the nature of the activity of the 
latent microsomal enzyme biphenyl 2-hydroxylase 
(Creaven, Parke &  Williams, 1965) has been 
investigated. This enzymic activity, although 
increasing after birth, contrasts with other hepatic 
drug-metabolizing enzymes in being absent from the 
livers of adult rats. A  preliminary account of this 
work has been given (Basu, Dickerson &  Parke,
1970).
M A T E R I A L S  A N D  M E T H O D S
Wistar albino rats were used throughout and main­
tained on a stock pellet diet (Spiller), and water ad lib. 
except where otherwise stated. Pregnant animals were 
separated from the stock and caged individually. In the 
first experiment litter size was maintained at three pups 
throughout the suckling period. Animals were weaned^ 
at 21 days, separated by sex and maintained in groups. 
U p  to 21 days of age animals of both sexes were used, but 
after 21 days males only were used. In the second experi­
ment, pregnant rats were reared throughout pregnancy on a 
synthetic diet containing 21% casein, 60% starch, 10% 
corn oil, 5 %  vitamin mixture (Cooper) and 4 %  mineral 
mixture. Litters were adjusted to eight pups at birth 
and the young were weaned at 21 days of age on to the 
same diet as that given to the mother.
In the first experiment, animals were killed by de­
capitation at intervals between 6 and 100 days and in the 
second experiment at intervals between 12 and 52 days 
of age. The livers were quickly removed, blotted, weighed 
and homogenized in ice-cold 1.15% (w/v) KC1 in a glass 
tube with a Teflon pestle, to give a final concentration of 
liver of 25% (w/v). Other 12-, 21- and 52-day-old animals 
were treated with phenobarbital (10 mg/kg) intraperi- 
toneally for 3 successive days and killed 24 h after 
the last dose. Liver homogenates of these animals were 
prepared as above.
Homogenates were centrifuged at lOOOOg for lOmin 
and the supernatant fractions centrifuged at 100000g- 
for lh to sediment the microsomal fraction. The lOOOOg- 
supernatant was used to measure biphenyl 2-hydroxylase 
and biphenyl 4-hydroxylase (Creaven et al. 1965), p- 
nitrobenzoate reductase (Bratton & Marshall, 1939) and 
4-methylumbelliferone glucuronyltransferase (Bollet, 
Goodwin & Bron, 1959). D N A  was separated from liver 
(Zamenhof, Bursztyn, Rich & Zamenhof, 1964) and 
determined by the diphenylamine reaction (Burton, 1956). 
Total and microsomal protein concentrations were deter­
mined by the method of Lowry, Rosebrough, Farr & 
Randall (1951). The content of cytochrome P-450 in the 
microsomal suspension was measured on a Unicam SP. 
800 spectrophotometer (Sladek & Mannering, 1966). To 
ensure that the biphenyl 2-hydroxylase and the biphenyl 
4-hydroxylase were liberated completely from membrane 
sites, various concentrations of Triton X-100 in KC1 were 
added to the 10 00Og supernatant of the liver homogenates 
and also to the resuspended microsomal preparations.
The incubation medium used for the microsomal suspen­
sion was supplemented by the addition of an N A D P H -  
generating system [glucose 6-phosphate (10/rmol in 
0.20 ml) and glucose 6-phosphate dehydrogenase (1.0 unit 
in 0.10ml)].
R E S U L T S
Effect of growth on liver weight and the activity of 
drug-metabolizing enzymes. Fig. 1 shows that the 
liver weight increased rapidly until 70 days of age 
and showed no change after 85 days. The body 
weight, however, increased until 100 days of age. 
The absolute amount of liver protein increased 
progressively until the age of 70 days and thereafter 
it remained more or less constant. Total microsomal 
protein followed a similar pattern of development 
with age. The progressive increase in the absolute 
amount of D N A ,  however, continued until 85 days 
of age.
The activity of 4-methylumbelliferone glucu­
ronyltransferase, expressed per g liver weight, per 
lOOg body weight and per unit of D N A ,  attained a 
m a x i m u m  value at 24 days, and subsequently 
declined to about 5 0 %  of this value at 52 days 
(Fig. 2). The activity of ^ -nitrobenzoate reductase 
expressed in all three parameters showed a peak 
activity at 38 days, which was followed by a slow 
decline to 6 0 %  of this value at 100 days (Fig. 3).
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Fig. 1. Effect of age on body weight and liver weight, 
protein content and D N A  content. Values for the first 
four ages are the means for four to 14 pooled samples of 
two to five livers. Values for later ages are the means of 
five to nine individual livers. ▲, Body weight (g); A, liver 
weight (g); B, total protein (mg); •, microsomal protein 
(mg); O, D N A  (mg).
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Cytochrome P-450 activity followed a similar 
pattern (Fig. 4) except that the peak was found to 
be at the age of 31 days, and this was followed by a 
sharp decrease at 38 days almost to the value for 
mature animals. The activity of biphenyl 4- 
hydroxylase showed a m a x i m u m  at 24 days of age, 
but unlike ^-nitrobenzoate reductase and cyto­
chrome P-450, the activity then decreased markedly 
to 4 0 %  of this m a x i m u m  value by 85 days (Fig. 5). 
Biphenyl 2-hydroxylase activity was maximal at 
21 days of age, but unlike the other four enzymes, 
fell to a negligible value by 52 days, and thereafter 
disappeared completely (Fig. 6).
300
250
100
Age (days)
Fig. 2. Effect of age on the activity of 4-methylumbelli­
ferone glucuronyltransferase in rat liver. Enzyme activity 
is expressed per lOOg body wt. (o), per g liver wt. (•) 
and per mg of D N A  (A).
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Fig. 3. Effect of age on the activity of ^ -nitrobenzoate 
reductase in rat liver. Enzyme activity is expressed per 
lOOg body wt. (o), per g liver wt. (•) and per mg of D N A  
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Fig. 4. Effect of age on the concentration of cytochrome 
P-450 in rat liver: per 100 g body wt. (o), per g liver wt. (•) 
and per mg of D N A  (A).
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Fig. 5. Effect of age on the activity of biphenyl 4-hydroxy­
lase in rat liver. Enzyme activity is expressed per 100 g 
body wt. (o), per g liver wt. (•) and per mg  of D N A  (A).
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Fig. 6. Effect of age on the activity of biphenyl 2-hydroxy­
lase in rat liver. Enzyme activity is expressed per lOOg 
body wt. (o), per g liver wt. (•) and per m g  of D N A  (A).
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Table 1 shows that the percentage induction of 
enzyme activity by phenobarbital decreased with 
age. In 12-day-old animals the induction was 
greatest for biphenyl 2-hydroxylase and least for 
^-nitrobenzoate reductase. In 52-day-old animals, 
however, the induction was greatest for biphenyl 
4-hydroxylase and negligible for p-nitrobenzoate 
reductase. The doses of phenobarbital used were 
below the m a x i m u m  (50-75mg/kg body wt.) of the 
dose-response curve. However, other work in our 
laboratory has shown that after induction by 
phenobarbital the K m of the enzymes studied is 
unchanged.
Effect of Triton X-100 on the activity of liver 
biphenyl 2- and 4-hydroxylases. It was considered 
that the observed loss of activity of biphenyl 
2-hydroxylase with increasing age might be due to 
increased binding of this membrane-bound enzyme. 
However, the addition of Triton X-100, a detergent 
that has been used to activate membrane-bound 
enzymes (Lueders &  Kuff, 1967) did not increase 
the activity of biphenyl 2-hydroxylase, but at 
0.1% Triton there was about 3 0 %  inhibition of the 
activity of biphenyl 4-hydroxylase.
Comparison of synthetic and stock diets. The 
offspring of pregnant rats that had been fed 
throughout gestation and lactation on the synthetic 
diet weighed less and grew more slowly than the 
offspring of female rats fed throughout on the stock 
diet. The liver weight relative to body weight of the 
rats on the synthetic diet followed the same pattern 
as that of those on the stock diet. Biphenyl 2- 
hydroxylase showed a consistently higher activity 
in rats fed on the synthetic diet. The activity of this 
enzyme was three times that in those rats that were 
weaned on to the synthetic diet, even when this
enzyme activity fell at 52 days of age (see Table 2). 
The amount of hepatic cytochrome P-450 was 
lower at all ages after weaning (18 days) in the rats 
fed on the synthetic diet. Activities of the other 
enzymes showed no significant changes caused by 
diet.
D I S C U S S I O N
The liver grew at a faster rate than the whole 
body up to 38 days of age, but after 52 days the 
body weight increased faster than the liver weight. 
Between 70 and 100 days of age the absolute weight 
and protein content of the liver remained constant. 
The body weight, however, continued to increase 
until 100 days of age, partly because of the accretion 
of body fat. The nuclei of rat liver cells show 
polyploidy (Davidson, 1953), but as the rat liver cell 
with a tetraploid nucleus is twice as large as that 
with a diploid nucleus the ratio cytoplasm weight/ 
unit weight of D N A  remains constant (Epstein, 
1967). It is therefore possible in this case to use 
D N A  for the expression of cellular constituents on 
a unit cell basis (Enesco &  Leblond, 1962).
The protein/DNA ratio, which m a y  be used as a 
measure of cell size, increased steadily until 32 days 
of age and showed a broad peak between 38 and 
85 days. This suggests that the cells of the liver 
m a y  be larger during the period of anabolism caused 
by puberty. The total amount of D N A  increases 
at different rates in different organs and reaches its 
adult value at different ages, and in the rat it is 
considered to reach its adult value in the liver at 
70 days of age (Winick &  Noble, 1965). In the liver 
of the rats used in our experiments, the total 
amount of liver D N A  appears to reach the mature 
value at 85 days of age.
Table 1. Effect of phenobarbital on the activity of liver microsomal enzymes at three different ages in  the
growing rat
The rats were treated with phenobarbital (10 mg/kg body wt. intraperitoneally) for 3 successive days, 
the last dose being given 24 h before death. The results are given as the mean + s.D. for at least six rats. 
The values in parentheses indicate the percentage increase in activity caused by phenobarbital.
Phenobarbital
treatment
Activity
Age (days) ... 12 21 52
Biphenyl 4-hydroxylase (^mol/h per g liver wt.) - 2.6 ±0.24 4.9 ±0.03 3.0±0.8
+ 6.8 + 0.27 8.0 +1.2 4.5 +0.7
(161%) (63%) (50%)
Biphenyl 2-hydroxylase (^mol/h per g liver wt.) — 0.15 + 0.05 0.30±0.05 0.04 ±0
+ 0.54 + 0.12 0.40 + 0.05 0.05 + 0
(260%) (30%) (25%)
p-Nitrobenzoate reductase (pmol/h per g liver wt.) — 0.42 ±0.02 0.90 ±0.06 1.2 + 0.34
+ 0.67 + 0.06 1.06 + 0.05 1.3 +  0.28
(60%) (18%) (8%)
Cytochrome P-450 (nmol/g liver wt.) — 13.0± 1.0 23.0±2.5 21.0±4.1
+ 24.0+1.9 38.0 + 6.0 27.0 + 3.8
(84%) (65%) (30%)
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Table 2. Comparison of the activities of liver microsomal enzymes in  rats whose parents were fed  throughout 
gestation and lactation on a stock diet and on a synthetic diet (21% casein), and who were themselves fed  on
the same diet from  weaning
Values given for the synthetic diet are means for four animals and for the stock diet are the means of the 
number of animals shown in Fig. 1. The results are given as the mean± s.D.
Diet
Activity
Age (days) ... 12 18 21 24 31 38 52
Biphenyl 2- Synthetic 0.70 ±0.04 1.30±0.03 2.20 ±0.02 2.20 ±0.04 2.00 ±0.03 1.9 ±0.02 0.53 ± 0
hydroxylase Stock 
(jumol/h per lOOg 
body wt.)
0.41 ±0.05 1.10±0.03 0.80 ±0.05 0.78 ±0.05 0.66 ±0.06 0.14 ±0.01
Biphenyl 4- Synthetic 7.90 ±0.07 16.0 ±0.3 20.0 ±0.2 26.0 ±2.2 23.1 ±0.5 22.0 ±0.1 17.4 ±0.4
hydroxylase Stock 
(jumol/h per 100 g 
body wt.)
8.50± 1.1 11.5±1.7 20.5±3.0 26.8 ±4.0 18.6±2.7 19.7 ±4.5 13.6±3.0
Cytochrome Synthetic 35.0 ±3.0 51.0±4.2 70.0 ±2.2 76.0 ±2.0 86.0 ±8.2 74.0 ±3.0 78.0±4.0
P-450 (nmol/ Stock 
100g body wt.)
39.0±3.3 49.0 ±4.5 93.0 ±9.3 92.0 ±11.5 125.0±7.8 86.0 ±18.0 96.0±18.0
p-Nitrobenzoate Synthetic 0.9 ±0.02 1.6 ±0.2 3.0 ±0.04 3.3 ±0.5 4.8 ±0.2 5.1 ±0.06 4.4 ±0.05
reductase Stock 
(jamol/h per 100 g 
body wt.)
1.2±0.1 3.1 ±0.4 3.3 ±0.8 3.9 ±0.5 5.4 ±1.4 6.8 ±0.5 5.4±0.5
The activity of each enzyme studied, when 
expressed per unit of body weight, rose to a peak 
soon aftor weaning (18-21 days) and then decreased 
with ago. This decrease was only partly accounted 
for by tho increase in the rate of growth of the body 
relative to that of the liver. With biphenyl 2- 
hydroxylase, the activity fell rapidly after 31 days 
and disappeared altogether at 70 days. The low 
activities of this enzyme were not due to decreased 
availability of enzyme sites caused by increased 
association of the enzyme with membranous 
elements of the endoplasmic reticulum, for there 
was no increase of activity when the detergent 
Triton X-100 was added. However, this result is 
not surprising because Tween 80, another m e m ­
brane-activating detergent, is already present in 
the incubation mixture necessary for the deter­
mination of this enzyme activity (Creaven et al. 
1965). This addition of Triton X-100 actually 
resulted in inhibition of the activity of the biphenyl 
4-hydroxylase. The reason for the disappearance 
of biphenyl 2-hydroxylase activity with increasing 
age is therefore still obscure. The activity of 
biphenyl 4-hydroxylase in mature rats, on the 
other hand, was about 4 0 %  of the m a x i m u m  value, 
and as with all other enzymes activities studied, 
with the exception of biphenyl 2-hydroxylase, 
remained constant after 52 days of age.
Phenobarbital induced the activity of the micro­
somal enzymes in rats of all ages, but the rate of 
induction was highest in the 12-day-old rats. This 
finding supports the work of Kato &  Takanaka 
(1968) who demonstrated that the induction by
phenobarbital of aminopyrine X-demethylation, 
hexobarbital hydroxylation, aniline hydroxylation 
and -nitrobenzoate reduction was m u c h  greater 
in 40-day-old rats than in older animals. Thus 
immature rats are intrinsically more responsive to 
enzyme induction.
The activity of biphenyl 2-hydroxylase was not 
increased at 52 days of age by the addition of 
Triton X-100 and treatment with phenobarbital 
failed to induce the enzyme. The induction of 
4-hydroxylation by phenobarbital to some extent 
paralleled the increase in cytochrome P-450, 
whereas the induction of 2-hydroxylation at 12 days 
was greatly in excess, and at 21 days, was m u c h  less. 
Therefore there would appear to be no correlation 
between 2-hydroxylation of biphenyl and amount 
of cytochrome P-450, although there m a y  be for 
4-hydroxylation. Thus biphenyl 2-hydroxylase is 
not likely to be affected via cytochrome P-450, but 
it is a microsomal enzyme, and like glucuronyl- 
transferase m a y  be expected to exist in different 
states of association with the endoplasmic reticulum 
and of availability to the substrate. If this is so, 
then it is far more difficult to establish than for 
glucuronyltransferase. Parke &  R a h m a n  (1970) 
have shown that the induction of 2-hydroxylase by 
safrole and isosafrole is due in part to protein 
synthesis. Similarly, the failure to induce biphenyl 
2-hydroxylase activity after 52 days of age is 
probably due to loss of ability to synthesize this 
particular protein. Biphenyl 2-hydroxylase also 
differed from the other hepatic microsomal enzymes 
studied in being consistently more active in rats
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fed on the synthetic diet. The reason for this higher 
activity m a y  be that the synthetic diet contained 
a higher concentration of utilizable protein.
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Activity of drug-m etabolizing enzym es in the liver of grow ing rats fed on  
diets high in sucrose, glucose, fructose or an equim olar m ixture of 
glucose and fructose. By J. W. T. D ic k e r s o n ,  T. K. B a su  and D. V. P a r k e ,  
Department of Biochemistry, University of Surrey, Guildford
Previous work has shown that the pattern of drug-metabolizing enzymes in the 
liver responds in different ways to the amount of protein in the diet and to the ratio 
of carbohydrate to protein (Dickerson, Basu & Parke, 1971). The present study is 
concerned with the response of these enzymes to various carbohydrates.
Male Wistar rats of similar body-weight were divided at 24'd of age into five 
groups. Group A was maintained on a diet containing 60% starch, and groups B, 
C, D and E on diets that were similar in every respect except that the starch was 
replaced by sucrose, glucose, fructose, or an equimolar mixture of glucose-{-fructose 
respectively. In the first experiment, ten animals were used in each group and these 
were killed after 14 d on the diet.
Since phenobarbitone in suitable doses is known to induce the drug-metabolizing 
enzymes, a second experiment was performed in which five animals on each of the 
five dietary regimens were given intraperitoneally a dose of 100 mg/kg body- 
weight of sodium phenobarbitone 24 h before killing.
The activities of biphenyl 4-hydroxylase, />-nitrobenzoate reductase and cyto­
chrome P-450 were determined in the liver as previously described (Basu, Dickerson 
& Parke, 1970).
In the first experiment, the liver weights tended to be higher in rats fed sucrose 
and the monosaccharides than in those fed starch. However, liver weights were 
significantly increased after phenobarbitone in all groups except the group fed 
sucrose. The specific activity of biphenyl 4-hydroxylase was lower in those animals 
fed sucrose or glucose-f-fructose than in those fed starch or glucose or fructose. 
After phenobarbitone, the activity in the starch-fed animals was higher than that in 
all other groups and the differences previously noted between the other groups had 
disappeared.
The specific activity of />-nitrobenzoate reductase was increased by fructose and 
glucose alone but not by sucrose or by the equimolar mixture of fructose and glucose. 
Phenobarbitone did not alter the pattern.
The effect of the various diets on cytochrome P-450 tended to be similar to that on 
biphenyl 4-hydroxylase in that sucrose and the monosaccharides tended to result in a 
decrease in specific activity. This pattern was enhanced by giving phenobarbitone.
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Protein nutrition and drug-m etabolizing enzym es in the liver of the 
grow ing rat. By J. W. T. D ic k e r s o n , T. K. B asu  and D. V. P a r k e , Department 
of Biochemistry, University of Surrey, Guildford
The rate of metabolism of drugs and the activity of NADPH-dependent enzymes 
in adult rat liver is closely related to the protein content of the diet (Kato, Oshima 
& Tomizawa, 1968; Marshall & McLean, 1969). However, other work has shown 
that a diet deficient in protein increases the resistance of adult rats to the toxic 
effects of carbon tetrachloride (McLean & McLean, 1966).
In the present experiments, male weanling Wistar rats were divided at 24 d of age 
into three groups. Group A (controls) were fed ad lib. a stock diet (Spillers, contain­
ing 21% protein). Group B (‘protein-deficient’) were fed the stock diet diluted to 
7% protein with pure potato starch with appropriate additions of minerals and 
vitamins. The food intake of these animals was recorded, and Group C (‘calorie- 
deficient’) were given the amount of stock diet containing the same amount of protein 
as that consumed by group B. In the first experiment, twenty-four animals were used 
in each group, and eight of them killed after 7, 14 and 28 d respectively on the diet. 
In a second experiment, ten animals reared on each of the three dietary regimens 
were given 10 mg/kg body-weight of phenobarbitone intraperitoneally on 3 
successive d until 24 h before killing in groups of five animals at 7 and 28 d 
respectively.
The activities of biphenyl 4-hydroxylase, ^-nitrobenzoate reductase, cytochrome 
P-450, and the amount of whole liver and microsomal protein were determined 
(Basu, Dickerson & Parke, 1970).
During 28 d on the different diets in the first experiment, the mean weights of the 
rats rose from 52 g to 210 g (group A), 143 g (group B) and 85 g (group C). The 
corresponding liver weights at this age were 9*6 g, 5*2 g and 2*9 g respectively. 
The results of the experiments, with and without induction of the enzymes with 
phenobarbitone, showed that in group C there was a deficit in the total activity of 
biphenyl 4-hydroxylase per liver whereas in group B there was a raised activity per 
g liver and a normal total activity. However, in group C there was a raised activity 
of />-nitrobenzoate reductase per g liver whereas in group B the activity per g liver
was normal. The result of these changes and of those in liver weight was that the
absolute amount of this enzyme was reduced to the same level by both deficient 
diets. At 28 d the activity of cytochrome P-450 per g liver weight was higher in 
group C than in group B.
Thus, biphenyl 4-hydroxylase, an oxidizing enzyme, is susceptible to a deficiency 
of total calories, whereas />-nitrobenzoate reductase is susceptible to the amount of 
protein and independent of calories.
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The Effect of Developm ent on the Activity of 
Drug-M etabolizing Enzym es in the Liver of 
the Rat
B y  T. K. Bask, J. W .  T. Dickerson and D. V. 
Parke. (Department of Biochemistry, U niversity 
of Surrey, Guildford, Surrey, U .K .)
The chemical development of rat liver has been 
studied extensively, but little information appears 
to be available on the changes in the activity of 
drug-metabolizing enzymes. The liver microsomes 
of newborn mice and rabbits are deficient in certain 
drug-metabolizing enzymes (Jondorf, Maickel &  
Brodie, 1958). The activity of these enzymes rises 
during the first 14 days after birth and by 28 days 
the activity is almost equal to that found in adult 
animals (Fouts &  Adamson, 1959). Similarly, 
newborn rats show little capacity to metabolize a 
number of drugs, and the capacity expressed per 
unit of microsomal protein progressively increases 
until 30 days of age; the metabolic capacity then 
decreases gradually with age (Kato, Vassanelli, 
Frontino &  Chiesara, 1964).
In the present study the activity of microsomal 
drug-metabolizing enzymes has been determined at 
various ages between 6 and 100 days after birth. 
The enzymes studied were biphenyl 2-hydroxylase 
and biphenyl 4-hydroxylase (Creaven, Parke &  
Williams, 1965),-nitrobenzoate reductase (Bratton 
&  Marshall, 1939) and cytochrome P-450 (Omura 
&  Sato, 1962). Microsomal protein (Lowry, Rose- 
brough, Farr &  Randall, 1951) and liver D N A  
(Zamenhof &  Chargaff, 1951) were also determined.
Liver weight relative to body weight gradually 
rose from 12 days of age to reach a peak value of
4.7% at 38 days, after which it slowly declined to 
3.7% at 100 days. The absolute amount of total 
protein in the liver rose to a m a x i m u m  value at 
70 days and remained constant thereafter. Micro­
somal protein followed a similar pattern. The 
absolute amount of D N A  reached a m a x i m u m  at 
85 days.
The activity of biphenyl 2-hydroxylase, expressed 
per g liver weight, per lOOg body weight and per 
unit of D N A  attained a m a x i m u m  value at 21 days 
and subsequently fell to an almost negligible value 
by 52 days. The m a x i m u m  activity of the biphenyl 
4-hydroxylase was reached at 24 days and sub­
sequently declined to 4 0 %  of this value at 85 days. 
The peak activity of -nitrobenzoate reductase 
was reached at 38 days, which was followed by a 
slow decline to 6 0 %  of this value at 100 days. The 
peak activity of cytochrome P-450 was reached at 
31 days, which was followed by a sharp fall to 
almost the value for mature animals at 38 days.
Possible explanations of the above changes in 
enzyme activity will be discussed.
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T h e  Effect of Diet on Hat Plasma Cortico­
steroids and Liver Aromatic Hydroxylase 
Activity
B y T . K . B a s u , J .  W . T. D i c k e r s o n  a n d  D .  V .  
P a r k e . (D epartm ent  o f  B iochem is try , Universi ty  
of Surrey ,  Guildford, Surrey ,  U .K .) '
There is evidence th a t  protein-deficient diets in 
children inay  resu lt in ad ap tiv e  changes of hepatic  
enzym es concerned w ith  in term ed iary  m etabolism  
an d  th a t  these  are  m ed ia ted  by  corticosteroid 
horm ones (Alleyne & Y oung, .1967; W aterlow , 
1938). F u rth e r, i t  1ms been shown th a t  th e  m icro ­
som al drug-m etabolizing enzymes of the  liver of 
grow ing ra ts  are dependent on the  d ie tary  intako of 
p ro tein  and  to ta l calorics (Dickerson, Basu & P arke ,
1971). .Tlieso drug-m etabolizing enzym es of tho  
liver are also concerned w ith  m etabolic dead  ivation  
o f th e  endogenous steroid  horm ones, and  the ir 
ac tiv ity  m ay bo increased by stress or ad m inistrat ion 
o f corticosteroids (Driovor, B ousquet &• M iva, 1900). 
I t  was thereforo decided to  ascertain  w hether the 
effect o f d ie t on tho  activ ities of th e  hepatic drug- 
m ctaboli/.ing enzym es observed previously were 
sim ilarly  m ed ia ted  th rough  corticosteroid h o r­
mones.
Male w eanling ra ts  (24 days old) were divided into 
th ree  groups: group A, controls, were fed ad lib. on 
stock d ie t (Spiller’s), 21%  p ro te in ; group B, 
‘protein-deficient’, were fed ad lib. on stock d iet 
d ilu ted  w ith  s tarch  to  contain  7%  p ro te in ; group C, 
‘protein- and  calorie-deficient’, were fed on sam e 
am oun t of p ro te in  as group B b u t w ithou t starch . 
L iver b iphenyl 4-hydroxylase ac tiv ity  w as d e te r­
m ined as a  m easure of hepatic d rug  m etabolism  
(Creaven, P a rk e  & W illiam s, 1905). L iver glycogen 
K em p & K its  van  H eijningen, 1954), glucose
G-phosphalase (Cori &  Cori, 1952) and plasma 
corticosteroids ((Mattingly, 19G2) wore also deter­
mined.
Tho protein-deficient animals (group B) after 2 
and 4 weeks on the diet showed increases in hepatic 
biphenyl 4-hydroxylase activity (70-100%) and 
plasma corticosterone (150-200%). Tho animals 
on tho diet deficient in both calories and protein 
(group C) showed only moderate increases in both 
liver biphenyl 4-hydroxylase activity (25—50%) and 
plasma corticostorone. Studies of the kinetics of the 
hepatic biphenyl 4-hydroxylaso activity showed 
that in both groups B  and C tho K m value was the 
same as controls (0.23 nil) but the F ma!c. was 
increased."
Wince the hepatic cytochrome P-450 in similar 
protein-deficient rats was either diminished or 
showed no change (Dickerson et al.  1971) and tho 
K m for the biphenyl 4-liydroxylaso was unchanged 
but tho rmax. increased, the increased hepatic 
biphenyl 4-hydroxylaso activity is unlikely to be 
duo to any change of tho active sites or in the total 
amount or the terminal oxygenase. It is more likely 
to l)e due to an increaso of some other component of 
the associated electron-transport chain, e.g. cyto- 
clu'ome P-450 reductase, or to some conformational . 
change of the membrano of the endoplasmic 
reticulum or change of tho membrane environment. 
Tho simultaneous increase in plasma corticosteroids 
and the known stimulat ing effect of these hormones i 
might suggest that the increases observed in tho 
hepatic drug-metabolizing enzyme were mediated 
through the endogenous steroid hormones.
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